HRP20040344A2 - N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors - Google Patents
N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitorsInfo
- Publication number
- HRP20040344A2 HRP20040344A2 HR20040344A HRP20040344A HRP20040344A2 HR P20040344 A2 HRP20040344 A2 HR P20040344A2 HR 20040344 A HR20040344 A HR 20040344A HR P20040344 A HRP20040344 A HR P20040344A HR P20040344 A2 HRP20040344 A2 HR P20040344A2
- Authority
- HR
- Croatia
- Prior art keywords
- phenyl
- methyl
- pyridin
- acetyl
- pyrrolidine
- Prior art date
Links
- -1 N-substituted pyrrolidin Chemical class 0.000 title claims description 432
- 229940124213 Dipeptidyl peptidase 4 (DPP IV) inhibitor Drugs 0.000 title 1
- 239000003603 dipeptidyl peptidase IV inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 396
- 150000003839 salts Chemical class 0.000 claims description 91
- 125000001424 substituent group Chemical group 0.000 claims description 90
- 229910052736 halogen Inorganic materials 0.000 claims description 81
- 150000002367 halogens Chemical class 0.000 claims description 80
- 238000011282 treatment Methods 0.000 claims description 77
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 71
- 238000000034 method Methods 0.000 claims description 68
- 125000001072 heteroaryl group Chemical group 0.000 claims description 63
- 125000000217 alkyl group Chemical group 0.000 claims description 56
- 125000003118 aryl group Chemical group 0.000 claims description 55
- 229910052739 hydrogen Inorganic materials 0.000 claims description 36
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 33
- 239000001257 hydrogen Substances 0.000 claims description 31
- 238000002360 preparation method Methods 0.000 claims description 30
- 238000006243 chemical reaction Methods 0.000 claims description 28
- 125000000623 heterocyclic group Chemical group 0.000 claims description 26
- 125000006163 5-membered heteroaryl group Chemical group 0.000 claims description 25
- 201000010099 disease Diseases 0.000 claims description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 25
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 claims description 23
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 claims description 23
- 125000004076 pyridyl group Chemical group 0.000 claims description 22
- 125000003545 alkoxy group Chemical group 0.000 claims description 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 238000011321 prophylaxis Methods 0.000 claims description 20
- 208000002705 Glucose Intolerance Diseases 0.000 claims description 18
- 201000009104 prediabetes syndrome Diseases 0.000 claims description 18
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 18
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 17
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims description 14
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims description 12
- 125000001544 thienyl group Chemical group 0.000 claims description 12
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 206010012601 diabetes mellitus Diseases 0.000 claims description 11
- 229910052760 oxygen Inorganic materials 0.000 claims description 11
- 206010009900 Colitis ulcerative Diseases 0.000 claims description 10
- 208000011231 Crohn disease Diseases 0.000 claims description 10
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 10
- 208000008589 Obesity Diseases 0.000 claims description 10
- 201000006704 Ulcerative Colitis Diseases 0.000 claims description 10
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 10
- 125000001624 naphthyl group Chemical group 0.000 claims description 10
- 235000020824 obesity Nutrition 0.000 claims description 10
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 10
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims description 10
- 125000000335 thiazolyl group Chemical group 0.000 claims description 10
- 125000001715 oxadiazolyl group Chemical group 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 7
- 125000002971 oxazolyl group Chemical group 0.000 claims description 7
- 239000013543 active substance Substances 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 150000002431 hydrogen Chemical group 0.000 claims description 6
- 125000003039 tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 claims description 6
- RHMINIBXILOOLC-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N RHMINIBXILOOLC-KRWDZBQOSA-N 0.000 claims description 5
- FNBGYGSBQXNGMV-AWEZNQCLSA-N (2s)-1-[2-[[2-methyl-1-[(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(ON=1)=NC=1C1=CC=CN=C1 FNBGYGSBQXNGMV-AWEZNQCLSA-N 0.000 claims description 5
- HPCVFMYWLKNCHA-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-pyridin-3-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=NC=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N HPCVFMYWLKNCHA-SFHVURJKSA-N 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 125000006289 hydroxybenzyl group Chemical group 0.000 claims description 5
- 125000001041 indolyl group Chemical group 0.000 claims description 5
- LHAUOAQRSGNEMT-SFHVURJKSA-N (2s)-1-[2-[2-[(5-phenylpyridin-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(N=C1)=CC=C1C1=CC=CC=C1 LHAUOAQRSGNEMT-SFHVURJKSA-N 0.000 claims description 4
- MMXPNIQJMULULS-INIZCTEOSA-N (2s)-1-[2-[2-[2-(4-fluorophenyl)-5-methyl-1,3-oxazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=CC(F)=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N MMXPNIQJMULULS-INIZCTEOSA-N 0.000 claims description 4
- UGRDWVKNSOHGRX-INIZCTEOSA-N (2s)-1-[2-[2-[[4-(3-phenyl-1,2-oxazol-5-yl)-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(SC=1)=NC=1C(ON=1)=CC=1C1=CC=CC=C1 UGRDWVKNSOHGRX-INIZCTEOSA-N 0.000 claims description 4
- BTQXXKSKFXDOPD-INIZCTEOSA-N (2s)-1-[2-[2-[[4-(4-cyanophenyl)-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(SC=1)=NC=1C1=CC=C(C#N)C=C1 BTQXXKSKFXDOPD-INIZCTEOSA-N 0.000 claims description 4
- VARXXRGAOGCJNM-KRWDZBQOSA-N (2s)-1-[2-[2-[[5-(2-methoxyphenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC=C1C(C=N1)=CC=C1NCCNCC(=O)N1[C@H](C#N)CCC1 VARXXRGAOGCJNM-KRWDZBQOSA-N 0.000 claims description 4
- CYUYIJUNEAEWTE-IBGZPJMESA-N (2s)-1-[2-[2-[[5-(4-cyanophenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(N=C1)=CC=C1C1=CC=C(C#N)C=C1 CYUYIJUNEAEWTE-IBGZPJMESA-N 0.000 claims description 4
- RZKAFKJWPUGAJH-SFHVURJKSA-N (2s)-1-[2-[2-[[5-(4-methoxyphenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C(C=N1)=CC=C1NCCNCC(=O)N1[C@H](C#N)CCC1 RZKAFKJWPUGAJH-SFHVURJKSA-N 0.000 claims description 4
- FEYLJXXHJSPVCN-YOEHRIQHSA-N (2s)-1-[2-[[(2s)-1-(2,3-dimethylindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=CC=CC=C2C(C)=C1C)C)CC(=O)N1CCC[C@H]1C#N FEYLJXXHJSPVCN-YOEHRIQHSA-N 0.000 claims description 4
- VUVQYJFNDZMWBF-IBGZPJMESA-N (2s)-1-[2-[[1-[[5-(4-methoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C(C=N1)=CC=C1NCC(C)(C)NCC(=O)N1[C@H](C#N)CCC1 VUVQYJFNDZMWBF-IBGZPJMESA-N 0.000 claims description 4
- OFPWYRCWIXVCKM-AWEZNQCLSA-N (2s)-1-[2-[[2-methyl-1-[(3-pyridin-4-yl-1,2,4-oxadiazol-5-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(ON=1)=NC=1C1=CC=NC=C1 OFPWYRCWIXVCKM-AWEZNQCLSA-N 0.000 claims description 4
- DOYXLXJWTNTMQD-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-4-(3-pyridin-3-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN(N=1)C=CC=1C1=CC=CN=C1 DOYXLXJWTNTMQD-KRWDZBQOSA-N 0.000 claims description 4
- BLGNGWMPCLADMR-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-pyrazin-2-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2N=CC=NC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N BLGNGWMPCLADMR-INIZCTEOSA-N 0.000 claims description 4
- VDBVGWZVLBCBIE-YOEHRIQHSA-N 1-[(2s)-2-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]propyl]indole-5-carbonitrile Chemical compound N([C@H](CN1C2=CC=C(C=C2C=C1)C#N)C)CC(=O)N1CCC[C@H]1C#N VDBVGWZVLBCBIE-YOEHRIQHSA-N 0.000 claims description 4
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 claims description 4
- 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 claims description 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 4
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 4
- 125000002883 imidazolyl group Chemical group 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- 125000001425 triazolyl group Chemical group 0.000 claims description 4
- KBVUIBGUSADKSG-SFHVURJKSA-N (2s)-1-[2-[2-[[5-(3-methoxyphenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC(C=2C=NC(NCCNCC(=O)N3[C@@H](CCC3)C#N)=CC=2)=C1 KBVUIBGUSADKSG-SFHVURJKSA-N 0.000 claims description 3
- OOFUHXAKVVLBKA-AWEZNQCLSA-N (2s)-1-[2-[2-[[5-(5-methyl-1,3,4-oxadiazol-2-yl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound O1C(C)=NN=C1C(C=N1)=CC=C1NCCNCC(=O)N1[C@H](C#N)CCC1 OOFUHXAKVVLBKA-AWEZNQCLSA-N 0.000 claims description 3
- PJDGWAXAFQNDBX-YOEHRIQHSA-N (2s)-1-[2-[[(2s)-1-(2-methylindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=CC=CC=C2C=C1C)C)CC(=O)N1CCC[C@H]1C#N PJDGWAXAFQNDBX-YOEHRIQHSA-N 0.000 claims description 3
- PACXNTNOHFGJKC-YOEHRIQHSA-N (2s)-1-[2-[[(2s)-1-(5-methoxy-2-methylindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@@H](C)CN1C2=CC=C(C=C2C=C1C)OC)CC(=O)N1CCC[C@H]1C#N PACXNTNOHFGJKC-YOEHRIQHSA-N 0.000 claims description 3
- RHDZIQUKUSTPHL-LSLKUGRBSA-N (2s)-1-[2-[[1-[(6-acetyl-4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridin-2-yl)amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound S1C=2CNC(C(=O)C)CC=2N=C1NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N RHDZIQUKUSTPHL-LSLKUGRBSA-N 0.000 claims description 3
- NFKNTRKCAYVDHL-ZDUSSCGKSA-N (2s)-1-[2-[[2-methyl-1-[(3-pyridin-2-yl-1,2,4-oxadiazol-5-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(ON=1)=NC=1C1=CC=CC=N1 NFKNTRKCAYVDHL-ZDUSSCGKSA-N 0.000 claims description 3
- KJRBPXVLFQZCBZ-HNNXBMFYSA-N (2s)-1-[2-[[2-methyl-1-[(5-phenyl-1,3,4-oxadiazol-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(O1)=NN=C1C1=CC=CC=C1 KJRBPXVLFQZCBZ-HNNXBMFYSA-N 0.000 claims description 3
- ZOLJOQLDVLKSLA-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-4-(2-methyl-4-pyridin-3-ylimidazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=NC(C=2C=NC=CC=2)=CN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N ZOLJOQLDVLKSLA-SFHVURJKSA-N 0.000 claims description 3
- AEOKIJDXJROCJQ-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-4-(4-pyridin-3-ylimidazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN(C=1)C=NC=1C1=CC=CN=C1 AEOKIJDXJROCJQ-KRWDZBQOSA-N 0.000 claims description 3
- KCPFBPIGKAWMLH-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-pyridin-3-yl-1,2,4-triazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=NC(C=2C=NC=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N KCPFBPIGKAWMLH-KRWDZBQOSA-N 0.000 claims description 3
- ZMCVWJADOONXIK-KSSFIOAISA-N 1-[(2s)-2-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]propyl]-2-methylindole-5-carbonitrile Chemical compound N([C@H](CN1C2=CC=C(C=C2C=C1C)C#N)C)CC(=O)N1CCC[C@H]1C#N ZMCVWJADOONXIK-KSSFIOAISA-N 0.000 claims description 3
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 3
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 3
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 125000002757 morpholinyl group Chemical group 0.000 claims description 3
- 125000003386 piperidinyl group Chemical group 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- SZHNGFHGTJBFMS-ZDUSSCGKSA-N (2s)-1-[2-[[1-(1,3-benzothiazol-2-ylamino)-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C2=CC=CC=C2SC=1NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N SZHNGFHGTJBFMS-ZDUSSCGKSA-N 0.000 claims description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000000972 4,5-dimethylthiazol-2-yl group Chemical group [H]C([H])([H])C1=C(N=C(*)S1)C([H])([H])[H] 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000004556 carbazol-9-yl group Chemical group C1=CC=CC=2C3=CC=CC=C3N(C12)* 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 2
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical group CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 claims 1
- KXCQDIWJQBSUJF-UHFFFAOYSA-N 4-phenyl-1,3-thiazole Chemical compound S1C=NC(C=2C=CC=CC=2)=C1 KXCQDIWJQBSUJF-UHFFFAOYSA-N 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 268
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 219
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 187
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 186
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 118
- 150000001412 amines Chemical class 0.000 description 103
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 90
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 87
- 229940098779 methanesulfonic acid Drugs 0.000 description 87
- 238000005160 1H NMR spectroscopy Methods 0.000 description 81
- 238000003818 flash chromatography Methods 0.000 description 76
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 72
- 239000000243 solution Substances 0.000 description 72
- 239000000203 mixture Substances 0.000 description 71
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 63
- 239000000843 powder Substances 0.000 description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 57
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 51
- 239000006260 foam Substances 0.000 description 51
- 239000000047 product Substances 0.000 description 51
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 51
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 45
- 235000011121 sodium hydroxide Nutrition 0.000 description 45
- 239000007787 solid Substances 0.000 description 45
- 239000000741 silica gel Substances 0.000 description 41
- 229910002027 silica gel Inorganic materials 0.000 description 41
- 238000004587 chromatography analysis Methods 0.000 description 39
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 38
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 38
- OPCJOXGBLDJWRM-UHFFFAOYSA-N 1,2-diamino-2-methylpropane Chemical compound CC(C)(N)CN OPCJOXGBLDJWRM-UHFFFAOYSA-N 0.000 description 37
- DOOZXVIPVZDJLE-UHFFFAOYSA-N tert-butyl n-[2-(carbamothioylamino)ethyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCNC(N)=S DOOZXVIPVZDJLE-UHFFFAOYSA-N 0.000 description 37
- 239000003480 eluent Substances 0.000 description 36
- 239000012458 free base Substances 0.000 description 36
- 239000007858 starting material Substances 0.000 description 34
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 33
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 32
- 239000003921 oil Substances 0.000 description 32
- 235000019198 oils Nutrition 0.000 description 32
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 30
- 230000015572 biosynthetic process Effects 0.000 description 30
- 238000003786 synthesis reaction Methods 0.000 description 30
- 239000002253 acid Substances 0.000 description 29
- 239000011541 reaction mixture Substances 0.000 description 29
- 239000000543 intermediate Substances 0.000 description 28
- 239000012044 organic layer Substances 0.000 description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 26
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 24
- 239000002244 precipitate Substances 0.000 description 22
- 239000002904 solvent Substances 0.000 description 22
- 239000000725 suspension Substances 0.000 description 21
- ZHXUWDPHUQHFOV-UHFFFAOYSA-N 2,5-dibromopyridine Chemical compound BrC1=CC=C(Br)N=C1 ZHXUWDPHUQHFOV-UHFFFAOYSA-N 0.000 description 20
- 230000002349 favourable effect Effects 0.000 description 20
- FEYDZHNIIMENOB-UHFFFAOYSA-N 2,6-dibromopyridine Chemical compound BrC1=CC=CC(Br)=N1 FEYDZHNIIMENOB-UHFFFAOYSA-N 0.000 description 19
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 19
- 235000019341 magnesium sulphate Nutrition 0.000 description 19
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- BHIWKHZACMWKOJ-UHFFFAOYSA-N methyl isobutyrate Chemical compound COC(=O)C(C)C BHIWKHZACMWKOJ-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 17
- 239000011521 glass Substances 0.000 description 17
- 239000002243 precursor Substances 0.000 description 17
- 230000009467 reduction Effects 0.000 description 16
- 238000006722 reduction reaction Methods 0.000 description 16
- 150000002460 imidazoles Chemical class 0.000 description 15
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 14
- 239000012267 brine Substances 0.000 description 14
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 14
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 14
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000012074 organic phase Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 12
- HVOLVGXBUGAQJF-VKHMYHEASA-N (4s)-4-methyl-2,2-dioxooxathiazolidine-3-carboxylic acid Chemical compound C[C@H]1COS(=O)(=O)N1C(O)=O HVOLVGXBUGAQJF-VKHMYHEASA-N 0.000 description 11
- QHRSESMSOJZMCO-UHFFFAOYSA-N 5-methyl-3-phenyl-1h-pyrazole Chemical compound N1C(C)=CC(C=2C=CC=CC=2)=N1 QHRSESMSOJZMCO-UHFFFAOYSA-N 0.000 description 11
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 11
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 235000011114 ammonium hydroxide Nutrition 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 238000010511 deprotection reaction Methods 0.000 description 10
- 239000000706 filtrate Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- RWEBPCTYBHXFPA-UHFFFAOYSA-N oxathiazinane-3-carboxylic acid Chemical compound OC(=O)N1CCCOS1 RWEBPCTYBHXFPA-UHFFFAOYSA-N 0.000 description 10
- 238000010992 reflux Methods 0.000 description 10
- VNDHYTGVCGVETQ-UHFFFAOYSA-N 4-fluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C=C1 VNDHYTGVCGVETQ-UHFFFAOYSA-N 0.000 description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 9
- 230000029936 alkylation Effects 0.000 description 9
- 238000005804 alkylation reaction Methods 0.000 description 9
- 150000001540 azides Chemical class 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- WDAXFOBOLVPGLV-UHFFFAOYSA-N isobutyric acid ethyl ester Natural products CCOC(=O)C(C)C WDAXFOBOLVPGLV-UHFFFAOYSA-N 0.000 description 9
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 239000007832 Na2SO4 Substances 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 150000001409 amidines Chemical class 0.000 description 8
- 239000007903 gelatin capsule Substances 0.000 description 8
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 150000003217 pyrazoles Chemical class 0.000 description 8
- 229910052938 sodium sulfate Inorganic materials 0.000 description 8
- 235000011152 sodium sulphate Nutrition 0.000 description 8
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical class C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- FSEUPUDHEBLWJY-HWKANZROSA-N diacetylmonoxime Chemical compound CC(=O)C(\C)=N\O FSEUPUDHEBLWJY-HWKANZROSA-N 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- HCBQTGAZENNMLM-UHFFFAOYSA-N methyl 4-bromo-3-oxopentanoate Chemical compound COC(=O)CC(=O)C(C)Br HCBQTGAZENNMLM-UHFFFAOYSA-N 0.000 description 7
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 7
- 238000007363 ring formation reaction Methods 0.000 description 7
- 238000010561 standard procedure Methods 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 6
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 6
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 6
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 239000012876 carrier material Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 6
- WOCIAKWEIIZHES-UHFFFAOYSA-N ruthenium(iv) oxide Chemical compound O=[Ru]=O WOCIAKWEIIZHES-UHFFFAOYSA-N 0.000 description 6
- NFAKQWFVEAEEPG-LURJTMIESA-N tert-butyl (4s)-4-methyl-2,2-dioxooxathiazolidine-3-carboxylate Chemical compound C[C@H]1COS(=O)(=O)N1C(=O)OC(C)(C)C NFAKQWFVEAEEPG-LURJTMIESA-N 0.000 description 6
- XDBHWPLGGBLUHH-UHFFFAOYSA-N (3-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C#N)=C1 XDBHWPLGGBLUHH-UHFFFAOYSA-N 0.000 description 5
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 5
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 5
- OFWWAPGRYMFUGP-UHFFFAOYSA-N 4-(bromomethyl)-5-methyl-2-phenyl-1,3-thiazole Chemical compound BrCC1=C(C)SC(C=2C=CC=CC=2)=N1 OFWWAPGRYMFUGP-UHFFFAOYSA-N 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 229910006124 SOCl2 Inorganic materials 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 235000019270 ammonium chloride Nutrition 0.000 description 5
- 239000012300 argon atmosphere Substances 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 239000012230 colorless oil Substances 0.000 description 5
- 239000002934 diuretic Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 125000006239 protecting group Chemical group 0.000 description 5
- QJRYYOWARFCJQZ-UHFFFAOYSA-N pyrrolidine-1-carbonitrile Chemical class N#CN1CCCC1 QJRYYOWARFCJQZ-UHFFFAOYSA-N 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 235000017550 sodium carbonate Nutrition 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 5
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 4
- CEBAHYWORUOILU-UHFFFAOYSA-N (4-cyanophenyl)boronic acid Chemical compound OB(O)C1=CC=C(C#N)C=C1 CEBAHYWORUOILU-UHFFFAOYSA-N 0.000 description 4
- IFPPZTSKNBSMHN-UHFFFAOYSA-N 2-(3-bromo-4-oxopentyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCC(Br)C(=O)C)C(=O)C2=C1 IFPPZTSKNBSMHN-UHFFFAOYSA-N 0.000 description 4
- BSQLQMLFTHJVKS-UHFFFAOYSA-N 2-chloro-1,3-benzothiazole Chemical compound C1=CC=C2SC(Cl)=NC2=C1 BSQLQMLFTHJVKS-UHFFFAOYSA-N 0.000 description 4
- BBVQDWDBTWSGHQ-UHFFFAOYSA-N 2-chloro-1,3-benzoxazole Chemical compound C1=CC=C2OC(Cl)=NC2=C1 BBVQDWDBTWSGHQ-UHFFFAOYSA-N 0.000 description 4
- VCTKYTBWZTZPHF-UHFFFAOYSA-N 4-(chloromethyl)-5-methyl-2-phenyl-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=CC=CC=2)=N1 VCTKYTBWZTZPHF-UHFFFAOYSA-N 0.000 description 4
- ZEZKXPQIDURFKA-UHFFFAOYSA-N 5-bromo-2-iodopyrimidine Chemical compound BrC1=CN=C(I)N=C1 ZEZKXPQIDURFKA-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 241000819038 Chichester Species 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 241000400611 Eucalyptus deanei Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000005909 Kieselgur Substances 0.000 description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 238000007126 N-alkylation reaction Methods 0.000 description 4
- 238000003482 Pinner synthesis reaction Methods 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- MKJPBOVLAZADQJ-UHFFFAOYSA-N [amino(pyridin-3-yl)methylidene]azanium;chloride Chemical compound Cl.NC(=N)C1=CC=CN=C1 MKJPBOVLAZADQJ-UHFFFAOYSA-N 0.000 description 4
- IONKMFGAXKCLMI-UHFFFAOYSA-N [amino(pyridin-4-yl)methylidene]azanium;chloride Chemical compound [Cl-].NC(=[NH2+])C1=CC=NC=C1 IONKMFGAXKCLMI-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 4
- 239000000920 calcium hydroxide Substances 0.000 description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 4
- 239000008108 microcrystalline cellulose Substances 0.000 description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- FTEAAYMAQFBUJJ-UHFFFAOYSA-N tert-butyl cyclopropanecarboxylate Chemical compound CC(C)(C)OC(=O)C1CC1 FTEAAYMAQFBUJJ-UHFFFAOYSA-N 0.000 description 4
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- MEFKFJOEVLUFAY-UHFFFAOYSA-N (2,2,2-trichloroacetyl) 2,2,2-trichloroacetate Chemical compound ClC(Cl)(Cl)C(=O)OC(=O)C(Cl)(Cl)Cl MEFKFJOEVLUFAY-UHFFFAOYSA-N 0.000 description 3
- PLBKMRKOPVQPTG-HNNXBMFYSA-N (2s)-1-[2-[(5-methyl-2-phenyl-1h-imidazol-4-yl)methylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CC=CC=2)=NC=1CNCC(=O)N1CCC[C@H]1C#N PLBKMRKOPVQPTG-HNNXBMFYSA-N 0.000 description 3
- SPWRZHSSTPPPIT-IBGZPJMESA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-phenylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=CC=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N SPWRZHSSTPPPIT-IBGZPJMESA-N 0.000 description 3
- LCGFVWKNXLRFIF-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-2-amine Chemical compound C1=CC=C2CC(N)CCC2=C1 LCGFVWKNXLRFIF-UHFFFAOYSA-N 0.000 description 3
- RLXCIUDSADDKPY-UHFFFAOYSA-N 2-(3-fluoro-4-methylphenyl)-5-methyl-4-(2-methyl-2-nitropropyl)-1h-imidazole Chemical compound [O-][N+](=O)C(C)(C)CC1=C(C)NC(C=2C=C(F)C(C)=CC=2)=N1 RLXCIUDSADDKPY-UHFFFAOYSA-N 0.000 description 3
- IZQQNHKYWQWWNE-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1h-imidazol-4-yl)ethanamine Chemical compound NCCC1=C(C)NC(C=2C=CC=CC=2)=N1 IZQQNHKYWQWWNE-UHFFFAOYSA-N 0.000 description 3
- SLVQWQFAVPIESL-UHFFFAOYSA-N 2-[3-(2-phenyl-1h-imidazol-5-yl)propyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCCC(N=1)=CNC=1C1=CC=CC=C1 SLVQWQFAVPIESL-UHFFFAOYSA-N 0.000 description 3
- FUQFEYDPXTXYSR-UHFFFAOYSA-N 3-(2-phenyl-1h-imidazol-5-yl)propan-1-amine Chemical compound NCCCC1=CNC(C=2C=CC=CC=2)=N1 FUQFEYDPXTXYSR-UHFFFAOYSA-N 0.000 description 3
- CGQOLRWLPQPKLV-UHFFFAOYSA-N 3-(5-methyl-1h-pyrazol-3-yl)pyridine Chemical compound N1C(C)=CC(C=2C=NC=CC=2)=N1 CGQOLRWLPQPKLV-UHFFFAOYSA-N 0.000 description 3
- JRWQLKZLTWPEBO-UHFFFAOYSA-N 3-(trifluoromethyl)benzenecarboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC=CC(C(F)(F)F)=C1 JRWQLKZLTWPEBO-UHFFFAOYSA-N 0.000 description 3
- LNFVYWSTTUBOOF-UHFFFAOYSA-N 4-(azidomethyl)-5-methyl-2-phenyl-1h-imidazole Chemical compound [N-]=[N+]=NCC1=C(C)NC(C=2C=CC=CC=2)=N1 LNFVYWSTTUBOOF-UHFFFAOYSA-N 0.000 description 3
- WOYTZASJYGTKTB-UHFFFAOYSA-N 4-(chloromethyl)-2-(2-chlorophenyl)-5-methyl-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C(=CC=CC=2)Cl)=N1 WOYTZASJYGTKTB-UHFFFAOYSA-N 0.000 description 3
- YDYSHKODLGBPQN-UHFFFAOYSA-N 4-[4-(chloromethyl)-1,3-thiazol-2-yl]morpholine Chemical compound ClCC1=CSC(N2CCOCC2)=N1 YDYSHKODLGBPQN-UHFFFAOYSA-N 0.000 description 3
- XYZWMVYYUIMRIZ-UHFFFAOYSA-N 4-bromo-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(Br)C=C1 XYZWMVYYUIMRIZ-UHFFFAOYSA-N 0.000 description 3
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 101000908391 Homo sapiens Dipeptidyl peptidase 4 Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 3
- 235000008206 alpha-amino acids Nutrition 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- CPEKAXYCDKETEN-UHFFFAOYSA-N benzoyl isothiocyanate Chemical compound S=C=NC(=O)C1=CC=CC=C1 CPEKAXYCDKETEN-UHFFFAOYSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000004737 colorimetric analysis Methods 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 102000045598 human DPP4 Human genes 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 238000012417 linear regression Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 235000011181 potassium carbonates Nutrition 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- ALJRPIAYJALVFG-UHFFFAOYSA-N tert-butyl 2,2-dioxooxathiazolidine-3-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCOS1(=O)=O ALJRPIAYJALVFG-UHFFFAOYSA-N 0.000 description 3
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 3
- SQTUYFKNCCBFRR-UHFFFAOYSA-N (2,4-dimethoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(OC)=C1 SQTUYFKNCCBFRR-UHFFFAOYSA-N 0.000 description 2
- GGRBEFVMJHQWFG-UHFFFAOYSA-N (2-phenyl-1h-imidazol-5-yl)methanol Chemical compound OCC1=CNC(C=2C=CC=CC=2)=N1 GGRBEFVMJHQWFG-UHFFFAOYSA-N 0.000 description 2
- RSVQEGSPMQMHAG-VIFPVBQESA-N (2s)-1-(5-methoxy-2-methylindol-1-yl)propan-2-amine Chemical compound COC1=CC=C2N(C[C@H](C)N)C(C)=CC2=C1 RSVQEGSPMQMHAG-VIFPVBQESA-N 0.000 description 2
- UKMHAPJWCGZLTD-HNNXBMFYSA-N (2s)-1-[2-(2-quinolin-6-yloxyethylamino)acetyl]pyrrolidine-2-carbonitrile Chemical compound C=1C=C2N=CC=CC2=CC=1OCCNCC(=O)N1CCC[C@H]1C#N UKMHAPJWCGZLTD-HNNXBMFYSA-N 0.000 description 2
- PKHHXFGDACLVRA-LBPRGKRZSA-N (2s)-1-[2-[2-(1,3-benzothiazol-2-ylamino)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C2=CC=CC=C2SC=1NCCNCC(=O)N1CCC[C@H]1C#N PKHHXFGDACLVRA-LBPRGKRZSA-N 0.000 description 2
- GCTAINOQEMWJTH-LBPRGKRZSA-N (2s)-1-[2-[2-(1,3-benzoxazol-2-ylamino)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C2=CC=CC=C2OC=1NCCNCC(=O)N1CCC[C@H]1C#N GCTAINOQEMWJTH-LBPRGKRZSA-N 0.000 description 2
- XTGKJTMOMCVKBE-AWEZNQCLSA-N (2s)-1-[2-[2-(4h-indeno[1,2-d][1,3]thiazol-2-ylamino)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C(C2=CC=CC=C2C2)=C2SC=1NCCNCC(=O)N1CCC[C@H]1C#N XTGKJTMOMCVKBE-AWEZNQCLSA-N 0.000 description 2
- YEVCNKUGPDWBES-INIZCTEOSA-N (2s)-1-[2-[2-(5-methoxy-2-methylindol-1-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC2=CC(OC)=CC=C2N1CCNCC(=O)N1CCC[C@H]1C#N YEVCNKUGPDWBES-INIZCTEOSA-N 0.000 description 2
- HTTDVZWBSOPMSX-INIZCTEOSA-N (2s)-1-[2-[2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1SC(C=2C=CC=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N HTTDVZWBSOPMSX-INIZCTEOSA-N 0.000 description 2
- PCEXCRJWYLTVIQ-INIZCTEOSA-N (2s)-1-[2-[2-(5-methyl-2-phenyl-1h-imidazol-4-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CC=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N PCEXCRJWYLTVIQ-INIZCTEOSA-N 0.000 description 2
- VDAJODZDQNMNFQ-LBPRGKRZSA-N (2s)-1-[2-[2-[(4,5-dimethyl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound S1C(C)=C(C)N=C1NCCNCC(=O)N1[C@H](C#N)CCC1 VDAJODZDQNMNFQ-LBPRGKRZSA-N 0.000 description 2
- PSQPPFLMGRKDAR-FQEVSTJZSA-N (2s)-1-[2-[2-[(4,5-diphenyl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(S1)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 PSQPPFLMGRKDAR-FQEVSTJZSA-N 0.000 description 2
- POXKFOYUHWJOIW-HNNXBMFYSA-N (2s)-1-[2-[2-[(4-benzoyl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(SC=1)=NC=1C(=O)C1=CC=CC=C1 POXKFOYUHWJOIW-HNNXBMFYSA-N 0.000 description 2
- PGGWPQVFVUNXHD-HNNXBMFYSA-N (2s)-1-[2-[2-[(4-phenyl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(SC=1)=NC=1C1=CC=CC=C1 PGGWPQVFVUNXHD-HNNXBMFYSA-N 0.000 description 2
- NRYZNHVJLZSYKS-ZDUSSCGKSA-N (2s)-1-[2-[2-[(4-pyridin-2-yl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(SC=1)=NC=1C1=CC=CC=N1 NRYZNHVJLZSYKS-ZDUSSCGKSA-N 0.000 description 2
- XUNQKHOVQCFHFX-KRWDZBQOSA-N (2s)-1-[2-[2-[2-(2-ethylpyridin-4-yl)-5-methyl-1,3-thiazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=NC(CC)=CC(C=2SC(C)=C(CCNCC(=O)N3[C@@H](CCC3)C#N)N=2)=C1 XUNQKHOVQCFHFX-KRWDZBQOSA-N 0.000 description 2
- JMNVICLDRDUPCC-INIZCTEOSA-N (2s)-1-[2-[2-[2-(3,5-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC(OC)=CC(C=2OC(C)=C(CCNCC(=O)N3[C@@H](CCC3)C#N)N=2)=C1 JMNVICLDRDUPCC-INIZCTEOSA-N 0.000 description 2
- ZBFUASGYIYOTRP-INIZCTEOSA-N (2s)-1-[2-[2-[2-(4-fluoro-3-methylphenyl)-5-methyl-1,3-oxazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=C(C)C(F)=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N ZBFUASGYIYOTRP-INIZCTEOSA-N 0.000 description 2
- DOBBTWHYDPHDKN-KRWDZBQOSA-N (2s)-1-[2-[2-[5-methyl-2-(3-methylphenyl)-1,3-thiazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1SC(C=2C=C(C)C=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N DOBBTWHYDPHDKN-KRWDZBQOSA-N 0.000 description 2
- ITQZLPLJJPHVQI-QFIPXVFZSA-N (2s)-1-[2-[2-[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N ITQZLPLJJPHVQI-QFIPXVFZSA-N 0.000 description 2
- QVPNXTZCPDVTJK-INIZCTEOSA-N (2s)-1-[2-[2-[5-methyl-2-(6-methylpyridin-3-yl)-1,3-thiazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1SC(C=2C=NC(C)=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N QVPNXTZCPDVTJK-INIZCTEOSA-N 0.000 description 2
- HRUURVQMSNCCGR-ZDUSSCGKSA-N (2s)-1-[2-[2-[[3-(5-methyl-1,3,4-oxadiazol-2-yl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound O1C(C)=NN=C1C1=CC=CN=C1NCCNCC(=O)N1[C@H](C#N)CCC1 HRUURVQMSNCCGR-ZDUSSCGKSA-N 0.000 description 2
- JESYLKWFOSQXGC-AWEZNQCLSA-N (2s)-1-[2-[2-[[4-(2-methoxyphenyl)-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC=C1C1=CSC(NCCNCC(=O)N2[C@@H](CCC2)C#N)=N1 JESYLKWFOSQXGC-AWEZNQCLSA-N 0.000 description 2
- DAGCOLAEXPKKOX-HNNXBMFYSA-N (2s)-1-[2-[2-[[4-(3-methoxyphenyl)-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC(C=2N=C(NCCNCC(=O)N3[C@@H](CCC3)C#N)SC=2)=C1 DAGCOLAEXPKKOX-HNNXBMFYSA-N 0.000 description 2
- GPCJUIGYFLUJCL-KRWDZBQOSA-N (2s)-1-[2-[2-[[4-(4-cyanophenyl)-5-methyl-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C(C=2C=CC(=CC=2)C#N)=C(C)SC=1NCCNCC(=O)N1CCC[C@H]1C#N GPCJUIGYFLUJCL-KRWDZBQOSA-N 0.000 description 2
- XGBUCABEWYOLIL-HNNXBMFYSA-N (2s)-1-[2-[2-[[4-(4-fluorophenyl)-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(F)=CC=C1C1=CSC(NCCNCC(=O)N2[C@@H](CCC2)C#N)=N1 XGBUCABEWYOLIL-HNNXBMFYSA-N 0.000 description 2
- YHPVDCZOHZLCRW-HNNXBMFYSA-N (2s)-1-[2-[2-[[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CSC(NCCNCC(=O)N2[C@@H](CCC2)C#N)=N1 YHPVDCZOHZLCRW-HNNXBMFYSA-N 0.000 description 2
- HSLJSIXMENLVMV-HNNXBMFYSA-N (2s)-1-[2-[2-[[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(C(F)(F)F)=CC=C1C1=CSC(NCCNCC(=O)N2[C@@H](CCC2)C#N)=N1 HSLJSIXMENLVMV-HNNXBMFYSA-N 0.000 description 2
- BITBKUGSEKOSIR-IBGZPJMESA-N (2s)-1-[2-[2-[[5-(3-cyanophenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(N=C1)=CC=C1C1=CC=CC(C#N)=C1 BITBKUGSEKOSIR-IBGZPJMESA-N 0.000 description 2
- ZSZFJAAIAWVNHU-INIZCTEOSA-N (2s)-1-[2-[2-[[5-methyl-4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C(C=2C=CC(=CC=2)C(F)(F)F)=C(C)SC=1NCCNCC(=O)N1CCC[C@H]1C#N ZSZFJAAIAWVNHU-INIZCTEOSA-N 0.000 description 2
- LZELXMUSWGUSDD-INIZCTEOSA-N (2s)-1-[2-[2-[[6-(2-methoxyphenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC=C1C1=CC=CC(NCCNCC(=O)N2[C@@H](CCC2)C#N)=N1 LZELXMUSWGUSDD-INIZCTEOSA-N 0.000 description 2
- BSVIVRLEGUMHJM-SFHVURJKSA-N (2s)-1-[2-[2-[[6-(3-cyanophenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(N=1)=CC=CC=1C1=CC=CC(C#N)=C1 BSVIVRLEGUMHJM-SFHVURJKSA-N 0.000 description 2
- YSJNARLKNAZFDL-KRWDZBQOSA-N (2s)-1-[2-[2-[[6-(3-methoxyphenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC(C=2N=C(NCCNCC(=O)N3[C@@H](CCC3)C#N)C=CC=2)=C1 YSJNARLKNAZFDL-KRWDZBQOSA-N 0.000 description 2
- VIOBHOZGLLQORW-KRWDZBQOSA-N (2s)-1-[2-[2-[[6-(4-methoxyphenyl)pyridin-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC=CC(NCCNCC(=O)N2[C@@H](CCC2)C#N)=N1 VIOBHOZGLLQORW-KRWDZBQOSA-N 0.000 description 2
- CIQNDVBDCPVSET-KRWDZBQOSA-N (2s)-1-[2-[3-(2-phenyl-1h-imidazol-5-yl)propylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCCC(N=1)=CNC=1C1=CC=CC=C1 CIQNDVBDCPVSET-KRWDZBQOSA-N 0.000 description 2
- SDJOQOCBSXTFDK-SFHVURJKSA-N (2s)-1-[2-[3-(5-methyl-3-phenylpyrazol-1-yl)propylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=CC=CC=2)=NN1CCCNCC(=O)N1CCC[C@H]1C#N SDJOQOCBSXTFDK-SFHVURJKSA-N 0.000 description 2
- PLFIXSUHKGKXFL-HOTGVXAUSA-N (2s)-1-[2-[[(2s)-1-(3-methylindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=CC=CC=C2C(C)=C1)C)CC(=O)N1CCC[C@H]1C#N PLFIXSUHKGKXFL-HOTGVXAUSA-N 0.000 description 2
- BXGQCVDMDYLKMT-BBRMVZONSA-N (2s)-1-[2-[[(2s)-1-(5-bromoindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=CC=C(Br)C=C2C=C1)C)CC(=O)N1CCC[C@H]1C#N BXGQCVDMDYLKMT-BBRMVZONSA-N 0.000 description 2
- PFSIKUWZOUWFFA-ZFWWWQNUSA-N (2s)-1-[2-[[(2s)-1-(7-bromoindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=C(Br)C=CC=C2C=C1)C)CC(=O)N1CCC[C@H]1C#N PFSIKUWZOUWFFA-ZFWWWQNUSA-N 0.000 description 2
- XNRVOEVSEVIWMD-RDJZCZTQSA-N (2s)-1-[2-[[(2s)-1-(7-methylindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=C(C)C=CC=C2C=C1)C)CC(=O)N1CCC[C@H]1C#N XNRVOEVSEVIWMD-RDJZCZTQSA-N 0.000 description 2
- VLUPTHXFTLCSAK-HOCLYGCPSA-N (2s)-1-[2-[[(2s)-1-[3-(4-methoxyphenyl)-1,2,4-triazol-1-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=NN(C[C@H](C)NCC(=O)N2[C@@H](CCC2)C#N)C=N1 VLUPTHXFTLCSAK-HOCLYGCPSA-N 0.000 description 2
- NSRSGTOVMCJUMZ-RDJZCZTQSA-N (2s)-1-[2-[[(2s)-1-[3-(4-methoxyphenyl)pyrazol-1-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=NN(C[C@H](C)NCC(=O)N2[C@@H](CCC2)C#N)C=C1 NSRSGTOVMCJUMZ-RDJZCZTQSA-N 0.000 description 2
- LJDMXVJBNLVADO-KBPBESRZSA-N (2s)-1-[2-[[(2s)-1-[5,6-dimethoxy-3-(2,2,2-trifluoroacetyl)indol-1-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@@H](C)CN1C=C(C=2C=C(C(=CC=21)OC)OC)C(=O)C(F)(F)F)CC(=O)N1CCC[C@H]1C#N LJDMXVJBNLVADO-KBPBESRZSA-N 0.000 description 2
- CCPNUSVEYHTWHY-YJBOKZPZSA-N (2s)-1-[2-[[(2s)-1-naphthalen-2-yloxypropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](COC=1C=C2C=CC=CC2=CC=1)C)CC(=O)N1CCC[C@H]1C#N CCPNUSVEYHTWHY-YJBOKZPZSA-N 0.000 description 2
- PTXMZCIPUKFSRG-ZFWWWQNUSA-N (2s)-1-[2-[[(2s)-1-pyrrolo[2,3-b]pyridin-1-ylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=NC=CC=C2C=C1)C)CC(=O)N1CCC[C@H]1C#N PTXMZCIPUKFSRG-ZFWWWQNUSA-N 0.000 description 2
- ZCCSXMXKIYIDDC-ZDUSSCGKSA-N (2s)-1-[2-[[1-(1,3-benzoxazol-2-ylamino)-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C2=CC=CC=C2OC=1NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N ZCCSXMXKIYIDDC-ZDUSSCGKSA-N 0.000 description 2
- IKIPAQSXEMXZMR-SFHVURJKSA-N (2s)-1-[2-[[1-(1,5-dimethyl-2-phenylimidazol-4-yl)-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1=C(C=2C=CC=CC=2)N(C)C(C)=C1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N IKIPAQSXEMXZMR-SFHVURJKSA-N 0.000 description 2
- BOXXDTPSACBYFU-IBGZPJMESA-N (2s)-1-[2-[[1-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CCCC1 BOXXDTPSACBYFU-IBGZPJMESA-N 0.000 description 2
- SFSDNYKHTMHVBJ-SFHVURJKSA-N (2s)-1-[2-[[1-[(5-methyl-2-phenyl-1,3-thiazol-4-yl)methyl]cyclobutyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1SC(C=2C=CC=CC=2)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CCC1 SFSDNYKHTMHVBJ-SFHVURJKSA-N 0.000 description 2
- HKXMUUKYCFLVFK-IBGZPJMESA-N (2s)-1-[2-[[1-[(5-methyl-2-phenyl-1,3-thiazol-4-yl)methyl]cyclopentyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1SC(C=2C=CC=CC=2)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CCCC1 HKXMUUKYCFLVFK-IBGZPJMESA-N 0.000 description 2
- VCNPDLIYTGYPQR-HNNXBMFYSA-N (2s)-1-[2-[[1-[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C(=CC=CC=2)Cl)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N VCNPDLIYTGYPQR-HNNXBMFYSA-N 0.000 description 2
- LDLZCDZIBWLTBR-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3,5-dimethoxyphenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC(OC)=CC(C=2NC(C)=C(CC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)N=2)=C1 LDLZCDZIBWLTBR-KRWDZBQOSA-N 0.000 description 2
- KHEDRGQUTGZTFN-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3-chloro-4-methylphenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(Cl)C(C)=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N KHEDRGQUTGZTFN-KRWDZBQOSA-N 0.000 description 2
- POHMEHNBLNHHEO-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3-chlorophenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(Cl)C=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N POHMEHNBLNHHEO-KRWDZBQOSA-N 0.000 description 2
- STWJIUXJODAVAR-SFHVURJKSA-N (2s)-1-[2-[[1-[2-(3-ethoxyphenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CCOC1=CC=CC(C=2NC(C)=C(CC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)N=2)=C1 STWJIUXJODAVAR-SFHVURJKSA-N 0.000 description 2
- IZZFMPMEBGYEKL-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3-fluoro-4-methylphenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(F)C(C)=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N IZZFMPMEBGYEKL-KRWDZBQOSA-N 0.000 description 2
- QRHLYQKJPBKCNJ-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3-fluorophenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(F)C=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N QRHLYQKJPBKCNJ-KRWDZBQOSA-N 0.000 description 2
- AUARGYMAZVYYRF-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(4-fluoro-3-methylphenyl)-5-methyl-1,3-oxazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=C(C)C(F)=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N AUARGYMAZVYYRF-KRWDZBQOSA-N 0.000 description 2
- YELAGDSCMBSLJT-KRWDZBQOSA-N (2s)-1-[2-[[1-[[2-(3-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl]cyclopropyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=C(Cl)C=CC=2)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CC1 YELAGDSCMBSLJT-KRWDZBQOSA-N 0.000 description 2
- FEZTXPFJDZVGPC-KRWDZBQOSA-N (2s)-1-[2-[[1-[[4-(4-cyanophenyl)-1,3-thiazol-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(SC=1)=NC=1C1=CC=C(C#N)C=C1 FEZTXPFJDZVGPC-KRWDZBQOSA-N 0.000 description 2
- YUUVUVCDKOVODH-SFHVURJKSA-N (2s)-1-[2-[[1-[[5-(2-methoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC=C1C(C=N1)=CC=C1NCC(C)(C)NCC(=O)N1[C@H](C#N)CCC1 YUUVUVCDKOVODH-SFHVURJKSA-N 0.000 description 2
- PMSAWAHZROJKBV-IBGZPJMESA-N (2s)-1-[2-[[1-[[5-(3-methoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC(C=2C=NC(NCC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)=CC=2)=C1 PMSAWAHZROJKBV-IBGZPJMESA-N 0.000 description 2
- VPGYVJHKLIVWOO-SFHVURJKSA-N (2s)-1-[2-[[1-[[5-(3-methoxyphenyl)pyrimidin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC(C=2C=NC(NCC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)=NC=2)=C1 VPGYVJHKLIVWOO-SFHVURJKSA-N 0.000 description 2
- HLEZCXMUAWCDAJ-FQEVSTJZSA-N (2s)-1-[2-[[1-[[5-(4-cyanophenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=CC=C1C1=CC=C(C#N)C=C1 HLEZCXMUAWCDAJ-FQEVSTJZSA-N 0.000 description 2
- KKLGOCOJJJPFAT-IBGZPJMESA-N (2s)-1-[2-[[1-[[5-(4-cyanophenyl)pyrimidin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=NC=C1C1=CC=C(C#N)C=C1 KKLGOCOJJJPFAT-IBGZPJMESA-N 0.000 description 2
- MSHZHVOVVSZVMD-IBGZPJMESA-N (2s)-1-[2-[[1-[[6-(3-cyanophenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC=CC(C#N)=C1 MSHZHVOVVSZVMD-IBGZPJMESA-N 0.000 description 2
- KBVKQYNKUFYEGB-SFHVURJKSA-N (2s)-1-[2-[[1-[[6-[3,5-bis(trifluoromethyl)phenyl]pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 KBVKQYNKUFYEGB-SFHVURJKSA-N 0.000 description 2
- XQVSNNJEJDGCKC-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-(1-methyl-2-phenylimidazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1=C(C=2C=CC=CC=2)N(C)C=C1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N XQVSNNJEJDGCKC-SFHVURJKSA-N 0.000 description 2
- LTRWQPOFWBBIED-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-(2-phenyl-1,3-thiazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CC(N=1)=CSC=1C1=CC=CC=C1 LTRWQPOFWBBIED-KRWDZBQOSA-N 0.000 description 2
- CDQSEFYJAHDJKS-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-(2-phenyl-1h-imidazol-5-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CC(N=1)=CNC=1C1=CC=CC=C1 CDQSEFYJAHDJKS-KRWDZBQOSA-N 0.000 description 2
- OQOPANNMFLRMHK-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-1-(2-piperidin-1-yl-1,3-thiazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CC(N=1)=CSC=1N1CCCCC1 OQOPANNMFLRMHK-INIZCTEOSA-N 0.000 description 2
- CGWSCRHECJCFFM-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-(5-methyl-2-phenyl-1h-imidazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CC=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N CGWSCRHECJCFFM-KRWDZBQOSA-N 0.000 description 2
- RNNYAKLIQFVGIF-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-1-(5-methyl-2-pyridin-4-yl-1h-imidazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CN=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N RNNYAKLIQFVGIF-INIZCTEOSA-N 0.000 description 2
- VNIIPMPCDWLGIQ-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-[(6-pyridin-3-ylpyridin-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC=CN=C1 VNIIPMPCDWLGIQ-KRWDZBQOSA-N 0.000 description 2
- VGAAMHXKAZHWTD-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-[5-methyl-2-(4-methylphenyl)-1h-imidazol-4-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CC(C)=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N VGAAMHXKAZHWTD-SFHVURJKSA-N 0.000 description 2
- OOLZQPWJCXBAIU-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-[5-methyl-2-[3-(trifluoromethyl)phenyl]-1h-imidazol-4-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(C=CC=2)C(F)(F)F)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N OOLZQPWJCXBAIU-KRWDZBQOSA-N 0.000 description 2
- GTEOUDWNSNUHBR-HNNXBMFYSA-N (2s)-1-[2-[[2-methyl-1-[[3-(6-methylpyridin-3-yl)-1,2,4-oxadiazol-5-yl]amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=NC(C)=CC=C1C1=NOC(NCC(C)(C)NCC(=O)N2[C@@H](CCC2)C#N)=N1 GTEOUDWNSNUHBR-HNNXBMFYSA-N 0.000 description 2
- CFOKSMQECCMQOJ-IBGZPJMESA-N (2s)-1-[2-[[2-methyl-1-[[5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=CC=C1C1=CC=CC(C(F)(F)F)=C1 CFOKSMQECCMQOJ-IBGZPJMESA-N 0.000 description 2
- SEOPKXPSMSEMHJ-IBGZPJMESA-N (2s)-1-[2-[[2-methyl-1-[[6-(3-methylphenyl)pyridin-2-yl]amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC=CC(C=2N=C(NCC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)C=CC=2)=C1 SEOPKXPSMSEMHJ-IBGZPJMESA-N 0.000 description 2
- GULGCOSVSYWUKG-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-[[6-[3-(trifluoromethyl)phenyl]pyridin-2-yl]amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC=CC(C(F)(F)F)=C1 GULGCOSVSYWUKG-SFHVURJKSA-N 0.000 description 2
- FPKOITPEGIQFJB-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-4-(2-methylbenzimidazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=NC2=CC=CC=C2N1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N FPKOITPEGIQFJB-INIZCTEOSA-N 0.000 description 2
- WZHJOWVFFNXXBY-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-4-(4-pyridin-2-ylimidazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN(C=1)C=NC=1C1=CC=CC=N1 WZHJOWVFFNXXBY-INIZCTEOSA-N 0.000 description 2
- KUNSHUPXMUJQPO-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-pyridin-2-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2N=CC=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N KUNSHUPXMUJQPO-KRWDZBQOSA-N 0.000 description 2
- TUSPGQODMDCSAM-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-thiophen-2-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2SC=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N TUSPGQODMDCSAM-INIZCTEOSA-N 0.000 description 2
- LBUVZDBQNUUWPB-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-4-[3-phenyl-5-(trifluoromethyl)pyrazol-1-yl]butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN(C(=C1)C(F)(F)F)N=C1C1=CC=CC=C1 LBUVZDBQNUUWPB-KRWDZBQOSA-N 0.000 description 2
- JZJLCUSTHDCQLY-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-4-[3-pyridin-3-yl-5-(trifluoromethyl)pyrazol-1-yl]butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN(C(=C1)C(F)(F)F)N=C1C1=CC=CN=C1 JZJLCUSTHDCQLY-INIZCTEOSA-N 0.000 description 2
- CZMAWGNOAABROS-IBGZPJMESA-N (2s)-1-[2-[[2-methyl-4-[5-methyl-3-[3-(trifluoromethyl)phenyl]pyrazol-1-yl]butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=C(C=CC=2)C(F)(F)F)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N CZMAWGNOAABROS-IBGZPJMESA-N 0.000 description 2
- YILHKPUIQPBPNS-FQEVSTJZSA-N (2s)-1-[2-[[4-(5-cyclopropyl-3-phenylpyrazol-1-yl)-2-methylbutan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN1N=C(C=2C=CC=CC=2)C=C1C1CC1 YILHKPUIQPBPNS-FQEVSTJZSA-N 0.000 description 2
- GJUFVMXADWIJON-IBGZPJMESA-N (2s)-1-[2-[[4-[3-(3-chlorophenyl)-5-methylpyrazol-1-yl]-2-methylbutan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=C(Cl)C=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N GJUFVMXADWIJON-IBGZPJMESA-N 0.000 description 2
- RCWDNGZKEPMULJ-JTQLQIEISA-N (2s)-1-naphthalen-2-yloxypropan-2-amine Chemical compound C1=CC=CC2=CC(OC[C@@H](N)C)=CC=C21 RCWDNGZKEPMULJ-JTQLQIEISA-N 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- CACDOAPSKQKVQR-UHFFFAOYSA-N (5-methyl-2-phenyl-1h-imidazol-4-yl)methanol;hydrochloride Chemical compound Cl.OCC1=C(C)NC(C=2C=CC=CC=2)=N1 CACDOAPSKQKVQR-UHFFFAOYSA-N 0.000 description 2
- BBVIDBNAYOIXOE-UHFFFAOYSA-N 1,2,4-oxadiazole Chemical class C=1N=CON=1 BBVIDBNAYOIXOE-UHFFFAOYSA-N 0.000 description 2
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 2
- QLXJFHWSYOTKDT-UHFFFAOYSA-N 1-[2-(3-fluoro-4-methylphenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-amine Chemical compound CC(N)(C)CC1=C(C)NC(C=2C=C(F)C(C)=CC=2)=N1 QLXJFHWSYOTKDT-UHFFFAOYSA-N 0.000 description 2
- PSCMHRYUSPRGQH-IBGZPJMESA-N 1-[3-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-3-methylbutyl]-2-methylindole-5-carbonitrile Chemical compound CC1=CC2=CC(C#N)=CC=C2N1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N PSCMHRYUSPRGQH-IBGZPJMESA-N 0.000 description 2
- XLUXAKJPHJEFKL-UHFFFAOYSA-N 1-ethylcyclobutane-1-carboxylic acid Chemical compound CCC1(C(O)=O)CCC1 XLUXAKJPHJEFKL-UHFFFAOYSA-N 0.000 description 2
- LDCANIZBPLLZTB-UHFFFAOYSA-N 1-n-(1,3-benzothiazol-2-yl)-2-methylpropane-1,2-diamine Chemical compound C1=CC=C2SC(NCC(C)(N)C)=NC2=C1 LDCANIZBPLLZTB-UHFFFAOYSA-N 0.000 description 2
- WAVMHBINKJNWDZ-UHFFFAOYSA-N 1-n-(5-bromopyridin-2-yl)-2-methylpropane-1,2-diamine Chemical compound CC(C)(N)CNC1=CC=C(Br)C=N1 WAVMHBINKJNWDZ-UHFFFAOYSA-N 0.000 description 2
- HUBQNIVJJPSBAV-UHFFFAOYSA-N 1-n-[5-(4-methoxyphenyl)pyridin-2-yl]-2-methylpropane-1,2-diamine Chemical compound C1=CC(OC)=CC=C1C1=CC=C(NCC(C)(C)N)N=C1 HUBQNIVJJPSBAV-UHFFFAOYSA-N 0.000 description 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 2
- MVXVYAKCVDQRLW-UHFFFAOYSA-N 1h-pyrrolo[2,3-b]pyridine Chemical compound C1=CN=C2NC=CC2=C1 MVXVYAKCVDQRLW-UHFFFAOYSA-N 0.000 description 2
- FDWQFKPIESFRHX-UHFFFAOYSA-N 2,2-dioxooxathiazolidine-3-carboxylic acid Chemical compound OC(=O)N1CCOS1(=O)=O FDWQFKPIESFRHX-UHFFFAOYSA-N 0.000 description 2
- SLMHHOVQRSSRCV-UHFFFAOYSA-N 2,3-dibromopyridine Chemical compound BrC1=CC=CN=C1Br SLMHHOVQRSSRCV-UHFFFAOYSA-N 0.000 description 2
- AHHQCRZKQHDXIY-UHFFFAOYSA-N 2-(1h-imidazol-5-yl)pyridine Chemical compound N1C=NC=C1C1=CC=CC=N1 AHHQCRZKQHDXIY-UHFFFAOYSA-N 0.000 description 2
- HIKGFQQQXRKEPA-UHFFFAOYSA-N 2-(2-chloropyridin-3-yl)-5-methyl-1,3,4-oxadiazole Chemical compound O1C(C)=NN=C1C1=CC=CN=C1Cl HIKGFQQQXRKEPA-UHFFFAOYSA-N 0.000 description 2
- PSKJVCNFAMZUFJ-UHFFFAOYSA-N 2-(5-bromo-4-oxopentyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCCC(=O)CBr)C(=O)C2=C1 PSKJVCNFAMZUFJ-UHFFFAOYSA-N 0.000 description 2
- LFWWGOVVMHFOKV-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-thiazol-4-yl)ethanol Chemical compound OCCC1=C(C)SC(C=2C=CC=CC=2)=N1 LFWWGOVVMHFOKV-UHFFFAOYSA-N 0.000 description 2
- SQFYYVFBLZUVBR-UHFFFAOYSA-N 2-(6-chloropyridin-3-yl)-5-methyl-1,3,4-oxadiazole Chemical compound O1C(C)=NN=C1C1=CC=C(Cl)N=C1 SQFYYVFBLZUVBR-UHFFFAOYSA-N 0.000 description 2
- RIDWRQPRYKGWRO-UHFFFAOYSA-N 2-(carbamothioylamino)ethylcarbamic acid Chemical compound NC(=S)NCCNC(O)=O RIDWRQPRYKGWRO-UHFFFAOYSA-N 0.000 description 2
- BIDCGVLZDMVKQX-UHFFFAOYSA-N 2-[2-(5-methyl-2-phenyl-1h-imidazol-4-yl)ethyl]isoindole-1,3-dione Chemical compound N=1C(CCN2C(C3=CC=CC=C3C2=O)=O)=C(C)NC=1C1=CC=CC=C1 BIDCGVLZDMVKQX-UHFFFAOYSA-N 0.000 description 2
- ZPAIZYXBVULVPQ-UHFFFAOYSA-N 2-[2-[(5-phenylpyridin-2-yl)amino]ethylamino]-1-pyrrolidin-1-ylethanone Chemical compound C1CCCN1C(=O)CNCCNC(N=C1)=CC=C1C1=CC=CC=C1 ZPAIZYXBVULVPQ-UHFFFAOYSA-N 0.000 description 2
- YOJAINBPWDBVCT-UHFFFAOYSA-N 2-[2-[[5-(4-methoxyphenyl)pyridin-2-yl]amino]ethylamino]-1-pyrrolidin-1-ylethanone Chemical compound C1=CC(OC)=CC=C1C(C=N1)=CC=C1NCCNCC(=O)N1CCCC1 YOJAINBPWDBVCT-UHFFFAOYSA-N 0.000 description 2
- GROQDXQFAFKDLG-UHFFFAOYSA-N 2-[5-methyl-2-(3-methylphenyl)-1,3-oxazol-4-yl]ethanol Chemical compound OCCC1=C(C)OC(C=2C=C(C)C=CC=2)=N1 GROQDXQFAFKDLG-UHFFFAOYSA-N 0.000 description 2
- OBZQBTMCGHWOBR-UHFFFAOYSA-N 2-aminoethylthiourea Chemical compound NCCNC(N)=S OBZQBTMCGHWOBR-UHFFFAOYSA-N 0.000 description 2
- XTBXGZOVSCTNEC-UHFFFAOYSA-N 2-bromo-1-(3-phenyl-1,2-oxazol-5-yl)ethanone Chemical compound O1C(C(=O)CBr)=CC(C=2C=CC=CC=2)=N1 XTBXGZOVSCTNEC-UHFFFAOYSA-N 0.000 description 2
- XQJAHBHCLXUGEP-UHFFFAOYSA-N 2-bromo-1-(4-methoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C=C1 XQJAHBHCLXUGEP-UHFFFAOYSA-N 0.000 description 2
- ZNDGPDKYFJXEPS-UHFFFAOYSA-N 2-chloro-1,3,4-oxadiazole Chemical class ClC1=NN=CO1 ZNDGPDKYFJXEPS-UHFFFAOYSA-N 0.000 description 2
- QSGNNXKJPIMRPO-UHFFFAOYSA-N 2-chloro-5-phenyl-1,3,4-oxadiazole Chemical compound O1C(Cl)=NN=C1C1=CC=CC=C1 QSGNNXKJPIMRPO-UHFFFAOYSA-N 0.000 description 2
- OCVXSFKKWXMYPF-UHFFFAOYSA-N 2-chloroimidazole Chemical compound ClC1=NC=CN1 OCVXSFKKWXMYPF-UHFFFAOYSA-N 0.000 description 2
- OIGMTISOAGXBQQ-UHFFFAOYSA-N 2-methyl-1-n-(4,5,6,7-tetrahydro-[1,3]thiazolo[5,4-c]pyridin-2-yl)propane-1,2-diamine Chemical compound C1CNCC2=C1N=C(NCC(C)(N)C)S2 OIGMTISOAGXBQQ-UHFFFAOYSA-N 0.000 description 2
- BHNHHSOHWZKFOX-UHFFFAOYSA-N 2-methyl-1H-indole Chemical compound C1=CC=C2NC(C)=CC2=C1 BHNHHSOHWZKFOX-UHFFFAOYSA-N 0.000 description 2
- PVKJYCITKPSXJJ-UHFFFAOYSA-N 2-methyl-1h-indole-5-carbonitrile Chemical compound N#CC1=CC=C2NC(C)=CC2=C1 PVKJYCITKPSXJJ-UHFFFAOYSA-N 0.000 description 2
- UQFQLAASUXKQTH-UHFFFAOYSA-N 2-methyl-4-(5-methyl-3-phenylpyrazol-1-yl)butan-2-amine Chemical compound CC(N)(C)CCN1C(C)=CC(C=2C=CC=CC=2)=N1 UQFQLAASUXKQTH-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- GOCQSQHVIVLYOG-UHFFFAOYSA-N 3,5-bis(trifluoromethyl)benzenecarboximidamide;hydrochloride Chemical compound [Cl-].NC(=[NH2+])C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 GOCQSQHVIVLYOG-UHFFFAOYSA-N 0.000 description 2
- FFLPJEKRAYZAMU-UHFFFAOYSA-N 3,5-dichlorobenzenecarboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC(Cl)=CC(Cl)=C1 FFLPJEKRAYZAMU-UHFFFAOYSA-N 0.000 description 2
- WEGYGNROSJDEIW-UHFFFAOYSA-N 3-Acetylpyridine Chemical compound CC(=O)C1=CC=CN=C1 WEGYGNROSJDEIW-UHFFFAOYSA-N 0.000 description 2
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 2
- KISQHILAOJSVET-UHFFFAOYSA-N 3-fluorobenzenecarboximidamide;hydron;chloride Chemical compound Cl.NC(=N)C1=CC=CC(F)=C1 KISQHILAOJSVET-UHFFFAOYSA-N 0.000 description 2
- YDBIEYOHXLUHLK-UHFFFAOYSA-N 3-methoxybenzenecarboximidamide;hydrochloride Chemical compound Cl.COC1=CC=CC(C(N)=N)=C1 YDBIEYOHXLUHLK-UHFFFAOYSA-N 0.000 description 2
- WGRPQCFFBRDZFV-UHFFFAOYSA-N 3-methylbenzamide Chemical compound CC1=CC=CC(C(N)=O)=C1 WGRPQCFFBRDZFV-UHFFFAOYSA-N 0.000 description 2
- NUFFXGAGGYWFAV-UHFFFAOYSA-N 3-methylbenzenecarbothioamide Chemical compound CC1=CC=CC(C(N)=S)=C1 NUFFXGAGGYWFAV-UHFFFAOYSA-N 0.000 description 2
- SEXJYJYRYDGHAT-UHFFFAOYSA-N 3-pyridin-3-yl-5-(trichloromethyl)-1,2,4-oxadiazole Chemical compound O1C(C(Cl)(Cl)Cl)=NC(C=2C=NC=CC=2)=N1 SEXJYJYRYDGHAT-UHFFFAOYSA-N 0.000 description 2
- YEJUYWDHZLZQRI-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-fluoro-3-methylphenyl)-5-methyl-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=C(C)C(F)=CC=2)=N1 YEJUYWDHZLZQRI-UHFFFAOYSA-N 0.000 description 2
- ANSKJZIDWXDAJW-UHFFFAOYSA-N 4-(chloromethyl)-2-phenyl-1,3-oxazole Chemical compound ClCC1=COC(C=2C=CC=CC=2)=N1 ANSKJZIDWXDAJW-UHFFFAOYSA-N 0.000 description 2
- ZFGZRQQZWBYRRB-UHFFFAOYSA-N 4-(trifluoromethyl)benzenecarboximidamide;dihydrate;hydrochloride Chemical compound O.O.[Cl-].NC(=[NH2+])C1=CC=C(C(F)(F)F)C=C1 ZFGZRQQZWBYRRB-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- CUZYFQTVILUYJN-UHFFFAOYSA-N 4-[2-[2-[(2-oxo-2-pyrrolidin-1-ylethyl)amino]ethylamino]-1,3-thiazol-4-yl]benzonitrile Chemical compound C1CCCN1C(=O)CNCCNC(SC=1)=NC=1C1=CC=C(C#N)C=C1 CUZYFQTVILUYJN-UHFFFAOYSA-N 0.000 description 2
- ZKMJBLCYAREOSJ-UHFFFAOYSA-N 4-bromo-3-oxopentanoic acid Chemical compound CC(Br)C(=O)CC(O)=O ZKMJBLCYAREOSJ-UHFFFAOYSA-N 0.000 description 2
- DTROPWKBAVYTIC-UHFFFAOYSA-N 4-fluoro-2-hydroxybenzamide Chemical compound NC(=O)C1=CC=C(F)C=C1O DTROPWKBAVYTIC-UHFFFAOYSA-N 0.000 description 2
- NRFKZFFVTGGEQF-UHFFFAOYSA-N 4-fluoro-3-methylbenzaldehyde Chemical compound CC1=CC(C=O)=CC=C1F NRFKZFFVTGGEQF-UHFFFAOYSA-N 0.000 description 2
- PAKRXFXJKMFKPU-UHFFFAOYSA-N 4-phenylmethoxybenzamide Chemical compound C1=CC(C(=O)N)=CC=C1OCC1=CC=CC=C1 PAKRXFXJKMFKPU-UHFFFAOYSA-N 0.000 description 2
- ORSQVELABPHSGL-UHFFFAOYSA-N 5-(trifluoromethyl)pyridine-2-carbothioamide Chemical compound NC(=S)C1=CC=C(C(F)(F)F)C=N1 ORSQVELABPHSGL-UHFFFAOYSA-N 0.000 description 2
- VTHKLCWOLNQWHB-UHFFFAOYSA-N 5-aminopentan-2-one Chemical class CC(=O)CCCN VTHKLCWOLNQWHB-UHFFFAOYSA-N 0.000 description 2
- VXWVFZFZYXOBTA-UHFFFAOYSA-N 5-bromo-1h-indole Chemical compound BrC1=CC=C2NC=CC2=C1 VXWVFZFZYXOBTA-UHFFFAOYSA-N 0.000 description 2
- AIDXHOVOUCHIPI-UHFFFAOYSA-N 5-chloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=NC=C(C(O)=O)C=C1Cl AIDXHOVOUCHIPI-UHFFFAOYSA-N 0.000 description 2
- VSWGLJOQFUMFOQ-UHFFFAOYSA-N 5-methoxy-2-methyl-1h-indole Chemical compound COC1=CC=C2NC(C)=CC2=C1 VSWGLJOQFUMFOQ-UHFFFAOYSA-N 0.000 description 2
- VBHUDUMOCHYQRM-UHFFFAOYSA-N 6-methylpyridine-3-carbothioamide Chemical compound CC1=CC=C(C(N)=S)C=N1 VBHUDUMOCHYQRM-UHFFFAOYSA-N 0.000 description 2
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 125000006847 BOC protecting group Chemical group 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- IYCHDNQCHLMLJZ-UHFFFAOYSA-N Nicoxamat Chemical compound ONC(=O)C1=CC=CN=C1 IYCHDNQCHLMLJZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- PDBLIZDCJGTRKX-ZDUSSCGKSA-N [(2S)-1-[6-(4-methoxyphenyl)indol-1-yl]propan-2-yl]carbamic acid Chemical compound COC1=CC=C(C=C1)C1=CC=C2C=CN(C2=C1)C[C@H](C)NC(O)=O PDBLIZDCJGTRKX-ZDUSSCGKSA-N 0.000 description 2
- JNSBEPKGFVENFS-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC=C1C(F)(F)F JNSBEPKGFVENFS-UHFFFAOYSA-N 0.000 description 2
- BPTABBGLHGBJQR-UHFFFAOYSA-N [3,5-bis(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 BPTABBGLHGBJQR-UHFFFAOYSA-N 0.000 description 2
- WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 2
- CKUAXEQHGKSLHN-UHFFFAOYSA-N [C].[N] Chemical compound [C].[N] CKUAXEQHGKSLHN-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 239000010779 crude oil Substances 0.000 description 2
- 125000004802 cyanophenyl group Chemical group 0.000 description 2
- 150000004985 diamines Chemical class 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 2
- DVJZXYGZKFZHQX-UHFFFAOYSA-N ethyl 3-bromo-4-oxopiperidine-1-carboxylate Chemical compound CCOC(=O)N1CCC(=O)C(Br)C1 DVJZXYGZKFZHQX-UHFFFAOYSA-N 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 2
- 150000002475 indoles Chemical class 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- IIHIJFJSXPDTNO-UHFFFAOYSA-N methyl cyclopentanecarboxylate Chemical compound COC(=O)C1CCCC1 IIHIJFJSXPDTNO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GBUILYNWHZTCFQ-UHFFFAOYSA-N n'-(1,3-thiazol-2-yl)ethane-1,2-diamine Chemical compound NCCNC1=NC=CS1 GBUILYNWHZTCFQ-UHFFFAOYSA-N 0.000 description 2
- GPAVVBBIMLROIO-UHFFFAOYSA-N n'-(4,5-dimethyl-1,3-thiazol-2-yl)ethane-1,2-diamine Chemical compound CC=1N=C(NCCN)SC=1C GPAVVBBIMLROIO-UHFFFAOYSA-N 0.000 description 2
- WZRTXAJQVKYENV-UHFFFAOYSA-N n-(2-methoxy-7,8-dihydro-5h-quinolin-6-ylidene)hydroxylamine Chemical compound C1C(=NO)CCC2=NC(OC)=CC=C21 WZRTXAJQVKYENV-UHFFFAOYSA-N 0.000 description 2
- KXBIARKNAZXRGC-UHFFFAOYSA-N n-(3-cyanophenyl)acetamide Chemical compound CC(=O)NC1=CC=CC(C#N)=C1 KXBIARKNAZXRGC-UHFFFAOYSA-N 0.000 description 2
- JRPLEMJJWQOVPT-IBGZPJMESA-N n-[3-[4-[2-[[2-[(2s)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-5-methyl-1h-imidazol-2-yl]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(C=2NC(C)=C(CC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)N=2)=C1 JRPLEMJJWQOVPT-IBGZPJMESA-N 0.000 description 2
- 239000012038 nucleophile Substances 0.000 description 2
- VMDHJFCXMLRQPZ-UHFFFAOYSA-N oxathiazinane Chemical compound C1CNSOC1 VMDHJFCXMLRQPZ-UHFFFAOYSA-N 0.000 description 2
- SGNPIGAGPRLGEJ-UHFFFAOYSA-N oxathiazolidine-3-carboxylic acid Chemical class OC(=O)N1CCOS1 SGNPIGAGPRLGEJ-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- 125000005544 phthalimido group Chemical group 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical compound OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- GMHCEDDZKAYPLB-UHFFFAOYSA-N pyridine-2-carboximidamide;hydrochloride Chemical compound [Cl-].NC(=[NH2+])C1=CC=CC=N1 GMHCEDDZKAYPLB-UHFFFAOYSA-N 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000008109 sodium starch glycolate Substances 0.000 description 2
- 229940079832 sodium starch glycolate Drugs 0.000 description 2
- 229920003109 sodium starch glycolate Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- RGWGRRBHQUREDE-UHFFFAOYSA-N tert-butyl 3-bromo-4-oxopiperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(=O)C(Br)C1 RGWGRRBHQUREDE-UHFFFAOYSA-N 0.000 description 2
- VPVJIWHWQFCPDW-UHFFFAOYSA-N tert-butyl n-[1-(benzoylcarbamothioylamino)-2-methylpropan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC(C)(C)CNC(=S)NC(=O)C1=CC=CC=C1 VPVJIWHWQFCPDW-UHFFFAOYSA-N 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 150000007979 thiazole derivatives Chemical class 0.000 description 2
- 150000003556 thioamides Chemical class 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- CFOAUYCPAUGDFF-UHFFFAOYSA-N tosmic Chemical compound CC1=CC=C(S(=O)(=O)C[N+]#[C-])C=C1 CFOAUYCPAUGDFF-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- RCHAZMLZDQGPHJ-UHFFFAOYSA-N (1-amino-2-methylpropan-2-yl)carbamic acid Chemical compound NCC(C)(C)NC(O)=O RCHAZMLZDQGPHJ-UHFFFAOYSA-N 0.000 description 1
- HQXMIADJNOCTDN-IBGZPJMESA-N (2S)-1-[2-[[2-methyl-4-[5-methyl-3-(6-methylpyridin-3-yl)pyrazol-1-yl]butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=NC(C)=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N HQXMIADJNOCTDN-IBGZPJMESA-N 0.000 description 1
- YCWRPKBYQZOLCD-LURJTMIESA-N (2s)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile Chemical compound ClCC(=O)N1CCC[C@H]1C#N YCWRPKBYQZOLCD-LURJTMIESA-N 0.000 description 1
- WUOZBACYMYYTOQ-CABZTGNLSA-N (2s)-1-[(2s)-2-aminopropanoyl]-n-(4-nitrophenyl)pyrrolidine-2-carboxamide Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([N+]([O-])=O)C=C1 WUOZBACYMYYTOQ-CABZTGNLSA-N 0.000 description 1
- IXXKHFCNKDPOQL-ZDUSSCGKSA-N (2s)-1-[2-[2-(4-chloroindol-1-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC=2C(Cl)=CC=CC=2N1CCNCC(=O)N1CCC[C@H]1C#N IXXKHFCNKDPOQL-ZDUSSCGKSA-N 0.000 description 1
- VMDZVTUSEUUNDO-HNNXBMFYSA-N (2s)-1-[2-[2-(5-bromo-2,3-dihydroindol-1-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1CC2=CC(Br)=CC=C2N1CCNCC(=O)N1CCC[C@H]1C#N VMDZVTUSEUUNDO-HNNXBMFYSA-N 0.000 description 1
- SBECHRRICIMPSK-AWEZNQCLSA-N (2s)-1-[2-[2-(5-methyl-2-pyridin-2-yl-1h-imidazol-4-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2N=CC=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N SBECHRRICIMPSK-AWEZNQCLSA-N 0.000 description 1
- YUWYPSNPWUCYHX-HNNXBMFYSA-N (2s)-1-[2-[2-(5-methyl-2-pyridin-3-yl-1h-imidazol-4-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=NC=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N YUWYPSNPWUCYHX-HNNXBMFYSA-N 0.000 description 1
- FTVBWQJPKYPFCZ-HNNXBMFYSA-N (2s)-1-[2-[2-(5-methyl-2-pyridin-4-yl-1h-imidazol-4-yl)ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CN=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N FTVBWQJPKYPFCZ-HNNXBMFYSA-N 0.000 description 1
- WJQIXXYHIOEHHU-AWEZNQCLSA-N (2s)-1-[2-[2-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(SC=1)=NC=1C1=CC=CN=C1 WJQIXXYHIOEHHU-AWEZNQCLSA-N 0.000 description 1
- BNJMLAHCGWZHRS-AWEZNQCLSA-N (2s)-1-[2-[2-[(4-pyridin-4-yl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(SC=1)=NC=1C1=CC=NC=C1 BNJMLAHCGWZHRS-AWEZNQCLSA-N 0.000 description 1
- WPZRXWUQIQTVMH-INIZCTEOSA-N (2s)-1-[2-[2-[(5-methyl-4-phenyl-1,3-thiazol-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C(C=2C=CC=CC=2)=C(C)SC=1NCCNCC(=O)N1CCC[C@H]1C#N WPZRXWUQIQTVMH-INIZCTEOSA-N 0.000 description 1
- HTBZXRRTXLIVRH-KRWDZBQOSA-N (2s)-1-[2-[2-[(6-phenylpyridin-2-yl)amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNCCNC(N=1)=CC=CC=1C1=CC=CC=C1 HTBZXRRTXLIVRH-KRWDZBQOSA-N 0.000 description 1
- IGBUTQYISGVZGT-INIZCTEOSA-N (2s)-1-[2-[2-[2-(2-ethoxy-4-fluorophenyl)-5-methyl-1,3-oxazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CCOC1=CC(F)=CC=C1C1=NC(CCNCC(=O)N2[C@@H](CCC2)C#N)=C(C)O1 IGBUTQYISGVZGT-INIZCTEOSA-N 0.000 description 1
- CSZIVDHCFUZFPR-INIZCTEOSA-N (2s)-1-[2-[2-[2-(4-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=CC(Cl)=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N CSZIVDHCFUZFPR-INIZCTEOSA-N 0.000 description 1
- DUGQFMDAHDOOCY-KRWDZBQOSA-N (2s)-1-[2-[2-[5-methyl-2-(3-methylphenyl)-1,3-oxazol-4-yl]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=C(C)C=CC=2)=NC=1CCNCC(=O)N1CCC[C@H]1C#N DUGQFMDAHDOOCY-KRWDZBQOSA-N 0.000 description 1
- BGQXHHDZYRPZGD-AWEZNQCLSA-N (2s)-1-[2-[2-[[4-(2,4-dimethoxyphenyl)-1,3-thiazol-2-yl]amino]ethylamino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC(OC)=CC=C1C1=CSC(NCCNCC(=O)N2[C@@H](CCC2)C#N)=N1 BGQXHHDZYRPZGD-AWEZNQCLSA-N 0.000 description 1
- BMSNFQHXLQMKQQ-RXVVDRJESA-N (2s)-1-[2-[[(2s)-1-(2-phenylindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C([C@H](C)NCC(=O)N1[C@@H](CCC1)C#N)N(C1=CC=CC=C1C=1)C=1C1=CC=CC=C1 BMSNFQHXLQMKQQ-RXVVDRJESA-N 0.000 description 1
- GELMDNGTOKMPBI-RDJZCZTQSA-N (2s)-1-[2-[[(2s)-1-(3-phenylpyrazol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C([C@H](C)NCC(=O)N1[C@@H](CCC1)C#N)N(N=1)C=CC=1C1=CC=CC=C1 GELMDNGTOKMPBI-RDJZCZTQSA-N 0.000 description 1
- AAFXGHWAYLOKTH-HOCLYGCPSA-N (2s)-1-[2-[[(2s)-1-(5,6-dimethoxyindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@@H](C)CN1C=CC=2C=C(C(=CC=21)OC)OC)CC(=O)N1CCC[C@H]1C#N AAFXGHWAYLOKTH-HOCLYGCPSA-N 0.000 description 1
- GOOXHSYWKAGWEM-YOEHRIQHSA-N (2s)-1-[2-[[(2s)-1-(5-methyl-3-phenyl-1,2,4-triazol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C([C@H](C)NCC(=O)N1[C@@H](CCC1)C#N)N(C(=N1)C)N=C1C1=CC=CC=C1 GOOXHSYWKAGWEM-YOEHRIQHSA-N 0.000 description 1
- WOOOMWAGOWKUHX-AVRDEDQJSA-N (2s)-1-[2-[[(2s)-1-(5-phenyl-2,3-dihydroindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C([C@H](C)NCC(=O)N1[C@@H](CCC1)C#N)N(C1=CC=2)CCC1=CC=2C1=CC=CC=C1 WOOOMWAGOWKUHX-AVRDEDQJSA-N 0.000 description 1
- ZCCONCUMMMILIW-BBRMVZONSA-N (2s)-1-[2-[[(2s)-1-(6-bromoindol-1-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=CC(Br)=CC=C2C=C1)C)CC(=O)N1CCC[C@H]1C#N ZCCONCUMMMILIW-BBRMVZONSA-N 0.000 description 1
- KSOACJCPGVZRCQ-AVRDEDQJSA-N (2s)-1-[2-[[(2s)-1-[6-(4-methoxyphenyl)-2,3-dihydroindol-1-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC=C(CCN2C[C@H](C)NCC(=O)N3[C@@H](CCC3)C#N)C2=C1 KSOACJCPGVZRCQ-AVRDEDQJSA-N 0.000 description 1
- ROZMOQONGYWXSK-IRXDYDNUSA-N (2s)-1-[2-[[(2s)-1-carbazol-9-ylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=CC=CC=C2C2=CC=CC=C21)C)CC(=O)N1CCC[C@H]1C#N ROZMOQONGYWXSK-IRXDYDNUSA-N 0.000 description 1
- UQBKOLFSVPTHFQ-ZFWWWQNUSA-N (2s)-1-[2-[[(2s)-1-indazol-1-ylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N([C@H](CN1C2=CC=CC=C2C=N1)C)CC(=O)N1CCC[C@H]1C#N UQBKOLFSVPTHFQ-ZFWWWQNUSA-N 0.000 description 1
- CRDHGLXOJFDIGN-SFHVURJKSA-N (2s)-1-[2-[[1-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]cyclobutyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CCC1 CRDHGLXOJFDIGN-SFHVURJKSA-N 0.000 description 1
- IUFXQRQHVPMQIA-KRWDZBQOSA-N (2s)-1-[2-[[1-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl]cyclopropyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=CC=CC=2)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CC1 IUFXQRQHVPMQIA-KRWDZBQOSA-N 0.000 description 1
- HYJJOCADUZZEDZ-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3,5-dichlorophenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(Cl)C=C(Cl)C=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N HYJJOCADUZZEDZ-KRWDZBQOSA-N 0.000 description 1
- AQOMYTKRKGWUQP-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3,5-difluorophenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(F)C=C(F)C=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N AQOMYTKRKGWUQP-KRWDZBQOSA-N 0.000 description 1
- NOHLWEOGAYWWRW-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(3-methoxyphenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC(C=2NC(C)=C(CC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)N=2)=C1 NOHLWEOGAYWWRW-KRWDZBQOSA-N 0.000 description 1
- IZGWEKTZLOWHAZ-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-(4-chlorophenyl)-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CC(Cl)=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N IZGWEKTZLOWHAZ-KRWDZBQOSA-N 0.000 description 1
- JRCRGVZQHCGRQU-KRWDZBQOSA-N (2s)-1-[2-[[1-[2-[3,5-bis(trifluoromethyl)phenyl]-5-methyl-1h-imidazol-4-yl]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N JRCRGVZQHCGRQU-KRWDZBQOSA-N 0.000 description 1
- YNYRGIDOUJMGNG-HNNXBMFYSA-N (2s)-1-[2-[[1-[[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl]cyclopropyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C(=CC=CC=2)Cl)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CC1 YNYRGIDOUJMGNG-HNNXBMFYSA-N 0.000 description 1
- HPTWZNUWQOQKRB-KRWDZBQOSA-N (2s)-1-[2-[[1-[[2-(4-fluoro-3-methylphenyl)-5-methyl-1,3-oxazol-4-yl]methyl]cyclopropyl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=C(C)C(F)=CC=2)=NC=1CC1(NCC(=O)N2[C@@H](CCC2)C#N)CC1 HPTWZNUWQOQKRB-KRWDZBQOSA-N 0.000 description 1
- GMVPSVUJLJKFBM-ZDUSSCGKSA-N (2s)-1-[2-[[1-[[3-(2-chloropyridin-4-yl)-1,2,4-oxadiazol-5-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(ON=1)=NC=1C1=CC=NC(Cl)=C1 GMVPSVUJLJKFBM-ZDUSSCGKSA-N 0.000 description 1
- NEIJMUZREJMNIO-HNNXBMFYSA-N (2s)-1-[2-[[1-[[3-(3,5-dichlorophenyl)-1,2,4-oxadiazol-5-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(ON=1)=NC=1C1=CC(Cl)=CC(Cl)=C1 NEIJMUZREJMNIO-HNNXBMFYSA-N 0.000 description 1
- JBTOJIQNGOLJRK-SFHVURJKSA-N (2s)-1-[2-[[1-[[5-(2,4-dimethoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC(OC)=CC=C1C(C=N1)=CC=C1NCC(C)(C)NCC(=O)N1[C@H](C#N)CCC1 JBTOJIQNGOLJRK-SFHVURJKSA-N 0.000 description 1
- DOXQSIDHHMOZGQ-FQEVSTJZSA-N (2s)-1-[2-[[1-[[5-(3-cyanophenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=CC=C1C1=CC=CC(C#N)=C1 DOXQSIDHHMOZGQ-FQEVSTJZSA-N 0.000 description 1
- WYFOJKXJBJJJBV-IBGZPJMESA-N (2s)-1-[2-[[1-[[5-(3-cyanophenyl)pyrimidin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=NC=C1C1=CC=CC(C#N)=C1 WYFOJKXJBJJJBV-IBGZPJMESA-N 0.000 description 1
- DEABKSVEBKEAHX-IBGZPJMESA-N (2s)-1-[2-[[1-[[5-[3,5-bis(trifluoromethyl)phenyl]pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=CC=C1C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 DEABKSVEBKEAHX-IBGZPJMESA-N 0.000 description 1
- KQOHDHXZGCYMHJ-KRWDZBQOSA-N (2s)-1-[2-[[1-[[6-(2,4-dimethoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC(OC)=CC=C1C1=CC=CC(NCC(C)(C)NCC(=O)N2[C@@H](CCC2)C#N)=N1 KQOHDHXZGCYMHJ-KRWDZBQOSA-N 0.000 description 1
- GEAPDTMQTKRCNM-KRWDZBQOSA-N (2s)-1-[2-[[1-[[6-(2-methoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC=C1C1=CC=CC(NCC(C)(C)NCC(=O)N2[C@@H](CCC2)C#N)=N1 GEAPDTMQTKRCNM-KRWDZBQOSA-N 0.000 description 1
- NXIJVELXWVQVOH-SFHVURJKSA-N (2s)-1-[2-[[1-[[6-(3-methoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound COC1=CC=CC(C=2N=C(NCC(C)(C)NCC(=O)N3[C@@H](CCC3)C#N)C=CC=2)=C1 NXIJVELXWVQVOH-SFHVURJKSA-N 0.000 description 1
- UCSVGWXZUJLFKE-IBGZPJMESA-N (2s)-1-[2-[[1-[[6-(4-cyanophenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC=C(C#N)C=C1 UCSVGWXZUJLFKE-IBGZPJMESA-N 0.000 description 1
- SVSOZPOHIQECGP-SFHVURJKSA-N (2s)-1-[2-[[1-[[6-(4-methoxyphenyl)pyridin-2-yl]amino]-2-methylpropan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound C1=CC(OC)=CC=C1C1=CC=CC(NCC(C)(C)NCC(=O)N2[C@@H](CCC2)C#N)=N1 SVSOZPOHIQECGP-SFHVURJKSA-N 0.000 description 1
- MGHRJDFLGDHANZ-HNNXBMFYSA-N (2s)-1-[2-[[2-methyl-1-(2-morpholin-4-yl-1,3-thiazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CC(N=1)=CSC=1N1CCOCC1 MGHRJDFLGDHANZ-HNNXBMFYSA-N 0.000 description 1
- SXQKRKTWVPFBKC-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-(2-phenyl-1,3-oxazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CC(N=1)=COC=1C1=CC=CC=C1 SXQKRKTWVPFBKC-KRWDZBQOSA-N 0.000 description 1
- WASOBBMHPHNCFB-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-(5-methyl-2-phenyl-1,3-thiazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1SC(C=2C=CC=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N WASOBBMHPHNCFB-KRWDZBQOSA-N 0.000 description 1
- NIHODFWTPNQSBY-HNNXBMFYSA-N (2s)-1-[2-[[2-methyl-1-(5-methyl-2-pyridin-2-yl-1h-imidazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2N=CC=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N NIHODFWTPNQSBY-HNNXBMFYSA-N 0.000 description 1
- WXTMOZBMWJURJV-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-1-(5-methyl-2-pyridin-3-yl-1h-imidazol-4-yl)propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=NC=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N WXTMOZBMWJURJV-INIZCTEOSA-N 0.000 description 1
- KAAQMQLTVFTUHP-AWEZNQCLSA-N (2s)-1-[2-[[2-methyl-1-[(1-methylbenzimidazol-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N=1C2=CC=CC=C2N(C)C=1NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N KAAQMQLTVFTUHP-AWEZNQCLSA-N 0.000 description 1
- XSJNUKMLYXWTEY-HNNXBMFYSA-N (2s)-1-[2-[[2-methyl-1-[(3-phenyl-1,2,4-oxadiazol-5-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(ON=1)=NC=1C1=CC=CC=C1 XSJNUKMLYXWTEY-HNNXBMFYSA-N 0.000 description 1
- UUSGCJMFZHTKHT-IBGZPJMESA-N (2s)-1-[2-[[2-methyl-1-[(5-phenylpyridin-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=CC=C1C1=CC=CC=C1 UUSGCJMFZHTKHT-IBGZPJMESA-N 0.000 description 1
- VLCSLTGVDZJPKX-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-[(5-phenylpyrimidin-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=NC=C1C1=CC=CC=C1 VLCSLTGVDZJPKX-SFHVURJKSA-N 0.000 description 1
- UMWLHSTUJKKUET-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-[(5-pyridin-3-ylpyridin-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=C1)=CC=C1C1=CC=CN=C1 UMWLHSTUJKKUET-SFHVURJKSA-N 0.000 description 1
- ZVKXIAGSOWXVAP-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-[(6-phenylpyridin-2-yl)amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC=CC=C1 ZVKXIAGSOWXVAP-SFHVURJKSA-N 0.000 description 1
- LSYISKVBJHFDRK-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-[5-methyl-2-(3-methylphenyl)-1,3-oxazol-4-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1OC(C=2C=C(C)C=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N LSYISKVBJHFDRK-SFHVURJKSA-N 0.000 description 1
- ZAHBFXDJHSIJEB-INIZCTEOSA-N (2s)-1-[2-[[2-methyl-1-[5-methyl-2-[3-(trifluoromethoxy)phenyl]-1h-imidazol-4-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=C(OC(F)(F)F)C=CC=2)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N ZAHBFXDJHSIJEB-INIZCTEOSA-N 0.000 description 1
- JIIHTWQKZDTOBV-KRWDZBQOSA-N (2s)-1-[2-[[2-methyl-1-[5-methyl-2-[4-(trifluoromethyl)phenyl]-1h-imidazol-4-yl]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC=1NC(C=2C=CC(=CC=2)C(F)(F)F)=NC=1CC(C)(C)NCC(=O)N1CCC[C@H]1C#N JIIHTWQKZDTOBV-KRWDZBQOSA-N 0.000 description 1
- SBDILVKRBHLWCY-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-1-[[6-[4-(trifluoromethyl)phenyl]pyridin-2-yl]amino]propan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CNC(N=1)=CC=CC=1C1=CC=C(C(F)(F)F)C=C1 SBDILVKRBHLWCY-SFHVURJKSA-N 0.000 description 1
- RHOADSWKFXUKHW-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-4-(3-methyl-5-pyridin-3-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN1N=C(C)C=C1C1=CC=CN=C1 RHOADSWKFXUKHW-SFHVURJKSA-N 0.000 description 1
- YAHWLPHBTOHCTM-FQEVSTJZSA-N (2s)-1-[2-[[2-methyl-4-(3-phenyl-5-propan-2-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC(C)C1=CC(C=2C=CC=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N YAHWLPHBTOHCTM-FQEVSTJZSA-N 0.000 description 1
- KLEZAJIWKSPNKS-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-4-(4-phenylimidazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN(C=1)C=NC=1C1=CC=CC=C1 KLEZAJIWKSPNKS-SFHVURJKSA-N 0.000 description 1
- JQRUGKDEZCOAKG-HNNXBMFYSA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-pyrazin-2-yl-1,2,4-triazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=NC(C=2N=CC=NC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N JQRUGKDEZCOAKG-HNNXBMFYSA-N 0.000 description 1
- ONYUGYYJGKOSJX-SFHVURJKSA-N (2s)-1-[2-[[2-methyl-4-(5-methyl-3-pyridin-4-ylpyrazol-1-yl)butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=CN=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N ONYUGYYJGKOSJX-SFHVURJKSA-N 0.000 description 1
- WEKWKMBDKPIARY-HNNXBMFYSA-N (2s)-1-[2-[[2-methyl-4-[3-pyridin-3-yl-5-(trifluoromethyl)-1,2,4-triazol-1-yl]butan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound N1([C@@H](CCC1)C#N)C(=O)CNC(C)(C)CCN(C(=N1)C(F)(F)F)N=C1C1=CC=CN=C1 WEKWKMBDKPIARY-HNNXBMFYSA-N 0.000 description 1
- JENCLEOQHLYOIR-FQEVSTJZSA-N (2s)-1-[2-[[4-(5-ethyl-3-phenylpyrazol-1-yl)-2-methylbutan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CCC1=CC(C=2C=CC=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N JENCLEOQHLYOIR-FQEVSTJZSA-N 0.000 description 1
- XJGOEYDPXGUURH-KRWDZBQOSA-N (2s)-1-[2-[[4-[3-(3,4-dichlorophenyl)-5-methylpyrazol-1-yl]-2-methylbutan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=C(Cl)C(Cl)=CC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N XJGOEYDPXGUURH-KRWDZBQOSA-N 0.000 description 1
- BHQFSAAQEXVFCK-SFHVURJKSA-N (2s)-1-[2-[[4-[3-(5-chloropyridin-3-yl)-5-methylpyrazol-1-yl]-2-methylbutan-2-yl]amino]acetyl]pyrrolidine-2-carbonitrile Chemical compound CC1=CC(C=2C=C(Cl)C=NC=2)=NN1CCC(C)(C)NCC(=O)N1CCC[C@H]1C#N BHQFSAAQEXVFCK-SFHVURJKSA-N 0.000 description 1
- DFOMENDIPMGQCH-ZDUSSCGKSA-N (2s)-1-[6-(4-methoxyphenyl)-2,3-dihydroindol-1-yl]propan-2-amine Chemical compound C1=CC(OC)=CC=C1C1=CC=C(CCN2C[C@H](C)N)C2=C1 DFOMENDIPMGQCH-ZDUSSCGKSA-N 0.000 description 1
- BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical compound CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- PEFAIXQRQMEFER-UHFFFAOYSA-N (4-hydroxy-2-methylbutan-2-yl)carbamic acid Chemical compound OCCC(C)(C)NC(O)=O PEFAIXQRQMEFER-UHFFFAOYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- JRZGPXSSNPTNMA-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=CC=C2C(N)CCCC2=C1 JRZGPXSSNPTNMA-UHFFFAOYSA-N 0.000 description 1
- 125000003626 1,2,4-triazol-1-yl group Chemical group [*]N1N=C([H])N=C1[H] 0.000 description 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical class C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
- GWSCUKVFGZTZIO-UHFFFAOYSA-N 1,5-dimethyl-4-(2-methyl-2-nitropropyl)-2-phenylimidazole Chemical compound CN1C(C)=C(CC(C)(C)[N+]([O-])=O)N=C1C1=CC=CC=C1 GWSCUKVFGZTZIO-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- WBPAOUHWPONFEQ-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)ethanone Chemical compound CC(=O)C1=CC=C(Cl)C(Cl)=C1 WBPAOUHWPONFEQ-UHFFFAOYSA-N 0.000 description 1
- UUWJBXKHMMQDED-UHFFFAOYSA-N 1-(3-chlorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(Cl)=C1 UUWJBXKHMMQDED-UHFFFAOYSA-N 0.000 description 1
- JGEDPUINHSWYLS-VIFPVBQESA-N 1-[(2s)-2-aminopropyl]indole-5-carbonitrile Chemical compound N#CC1=CC=C2N(C[C@@H](N)C)C=CC2=C1 JGEDPUINHSWYLS-VIFPVBQESA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- RRUYWEJLUCRFKH-QMMMGPOBSA-N 1-[1-[(2s)-2-aminopropyl]-5,6-dimethoxyindol-3-yl]-2,2,2-trifluoroethanone Chemical compound C1=C(OC)C(OC)=CC2=C1N(C[C@H](C)N)C=C2C(=O)C(F)(F)F RRUYWEJLUCRFKH-QMMMGPOBSA-N 0.000 description 1
- AFKBISQFQWIWNE-UHFFFAOYSA-N 1-[2-[(2-amino-2-methylpropyl)amino]-6,7-dihydro-4h-[1,3]thiazolo[5,4-c]pyridin-5-yl]ethanone Chemical compound C1N(C(=O)C)CCC2=C1SC(NCC(C)(C)N)=N2 AFKBISQFQWIWNE-UHFFFAOYSA-N 0.000 description 1
- UYHTUQHYGKAYJM-UHFFFAOYSA-N 1-[3-(trifluoromethoxy)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(OC(F)(F)F)=C1 UYHTUQHYGKAYJM-UHFFFAOYSA-N 0.000 description 1
- ABXGMGUHGLQMAW-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]ethanone Chemical compound CC(=O)C1=CC=CC(C(F)(F)F)=C1 ABXGMGUHGLQMAW-UHFFFAOYSA-N 0.000 description 1
- POZHVHBTFKOUEN-UHFFFAOYSA-N 1-ethylcyclopropane-1-carboxylic acid Chemical compound CCC1(C(O)=O)CC1 POZHVHBTFKOUEN-UHFFFAOYSA-N 0.000 description 1
- CWOXKUXWYBNNLR-UHFFFAOYSA-N 1-methyl-4-(2-methyl-2-nitropropyl)-2-phenylimidazole Chemical compound CN1C=C(CC(C)(C)[N+]([O-])=O)N=C1C1=CC=CC=C1 CWOXKUXWYBNNLR-UHFFFAOYSA-N 0.000 description 1
- CVBUKMMMRLOKQR-UHFFFAOYSA-N 1-phenylbutane-1,3-dione Chemical compound CC(=O)CC(=O)C1=CC=CC=C1 CVBUKMMMRLOKQR-UHFFFAOYSA-N 0.000 description 1
- YHYLDEVWYOFIJK-UHFFFAOYSA-N 1h-indole-5-carbonitrile Chemical compound N#CC1=CC=C2NC=CC2=C1 YHYLDEVWYOFIJK-UHFFFAOYSA-N 0.000 description 1
- OFUCCBIWEUKISP-UHFFFAOYSA-N 2,2,2-trifluoroacetohydrazide Chemical compound NNC(=O)C(F)(F)F OFUCCBIWEUKISP-UHFFFAOYSA-N 0.000 description 1
- ROTJUFONINCKPE-UHFFFAOYSA-N 2,2-dimethyl-3-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propanoic acid Chemical compound OC(=O)C(C)(C)CC1=C(C)OC(C=2C=CC=CC=2)=N1 ROTJUFONINCKPE-UHFFFAOYSA-N 0.000 description 1
- PYFVEIDRTLBMHG-UHFFFAOYSA-N 2,3-dimethyl-1h-indole Chemical compound C1=CC=C2C(C)=C(C)NC2=C1 PYFVEIDRTLBMHG-UHFFFAOYSA-N 0.000 description 1
- LZKZDAMNFOVXBN-UHFFFAOYSA-N 2,6-dimethylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C(C)=N1 LZKZDAMNFOVXBN-UHFFFAOYSA-N 0.000 description 1
- SPYMAQJEMKZIKZ-UHFFFAOYSA-N 2-(2-phenyl-1h-imidazol-5-yl)ethanamine Chemical compound NCCC1=CNC(C=2C=CC=CC=2)=N1 SPYMAQJEMKZIKZ-UHFFFAOYSA-N 0.000 description 1
- APIKJDSKWUQCFE-UHFFFAOYSA-N 2-(5-methyl-1h-1,2,4-triazol-3-yl)pyrazine Chemical compound N1C(C)=NC(C=2N=CC=NC=2)=N1 APIKJDSKWUQCFE-UHFFFAOYSA-N 0.000 description 1
- OLHUHWHQNDWHJS-UHFFFAOYSA-N 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethanamine Chemical compound NCCC1=C(C)OC(C=2C=CC=CC=2)=N1 OLHUHWHQNDWHJS-UHFFFAOYSA-N 0.000 description 1
- RJMWEZDCGAXBLF-UHFFFAOYSA-N 2-[2-(2-ethoxy-4-fluorophenyl)-5-methyl-1,3-oxazol-4-yl]ethanol Chemical compound CCOC1=CC(F)=CC=C1C1=NC(CCO)=C(C)O1 RJMWEZDCGAXBLF-UHFFFAOYSA-N 0.000 description 1
- FFZPXRKJSAVMIP-UHFFFAOYSA-N 2-[2-(2-ethylpyridin-4-yl)-5-methyl-1,3-thiazol-4-yl]ethanol Chemical compound C1=NC(CC)=CC(C=2SC(C)=C(CCO)N=2)=C1 FFZPXRKJSAVMIP-UHFFFAOYSA-N 0.000 description 1
- GZPGEJIDZVSBOD-UHFFFAOYSA-N 2-[2-(3,5-dimethoxyphenyl)-5-methyl-1,3-oxazol-4-yl]ethanol Chemical compound COC1=CC(OC)=CC(C=2OC(C)=C(CCO)N=2)=C1 GZPGEJIDZVSBOD-UHFFFAOYSA-N 0.000 description 1
- XEOFBNBBWJTDHH-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)-5-methyl-1,3-oxazol-4-yl]ethanol Chemical compound OCCC1=C(C)OC(C=2C=CC(F)=CC=2)=N1 XEOFBNBBWJTDHH-UHFFFAOYSA-N 0.000 description 1
- IEEKOXYBRRCMCX-UHFFFAOYSA-N 2-[5-methyl-2-(3-methylphenyl)-1,3-thiazol-4-yl]ethanol Chemical compound OCCC1=C(C)SC(C=2C=C(C)C=CC=2)=N1 IEEKOXYBRRCMCX-UHFFFAOYSA-N 0.000 description 1
- FCZWKCUGEUATRA-UHFFFAOYSA-N 2-[5-methyl-2-(4-phenylmethoxyphenyl)-1,3-oxazol-4-yl]ethanol Chemical compound OCCC1=C(C)OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)=N1 FCZWKCUGEUATRA-UHFFFAOYSA-N 0.000 description 1
- WHLJBPIUPUAEBU-UHFFFAOYSA-N 2-[5-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]-1,3-thiazol-4-yl]ethanol Chemical compound OCCC1=C(C)SC(C=2N=CC(=CC=2)C(F)(F)F)=N1 WHLJBPIUPUAEBU-UHFFFAOYSA-N 0.000 description 1
- HTFXWAOSQODIBI-UHFFFAOYSA-N 2-benzyl-1,3-dihydropyrrolo[3,4-c]pyridine Chemical compound C1C2=CC=NC=C2CN1CC1=CC=CC=C1 HTFXWAOSQODIBI-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- PKVBZABQCCQHLD-UHFFFAOYSA-N 2-bromo-1-(2,4-dimethoxyphenyl)ethanone Chemical compound COC1=CC=C(C(=O)CBr)C(OC)=C1 PKVBZABQCCQHLD-UHFFFAOYSA-N 0.000 description 1
- GKNCPTLOPRDYMH-UHFFFAOYSA-N 2-bromo-1-(2-methoxyphenyl)ethanone Chemical compound COC1=CC=CC=C1C(=O)CBr GKNCPTLOPRDYMH-UHFFFAOYSA-N 0.000 description 1
- IOOHBIFQNQQUFI-UHFFFAOYSA-N 2-bromo-1-(3-methoxyphenyl)ethanone Chemical compound COC1=CC=CC(C(=O)CBr)=C1 IOOHBIFQNQQUFI-UHFFFAOYSA-N 0.000 description 1
- ZJFWCELATJMDNO-UHFFFAOYSA-N 2-bromo-1-(4-fluorophenyl)ethanone Chemical compound FC1=CC=C(C(=O)CBr)C=C1 ZJFWCELATJMDNO-UHFFFAOYSA-N 0.000 description 1
- HEMROKPXTCOASZ-UHFFFAOYSA-N 2-bromo-1-[4-(trifluoromethyl)phenyl]ethanone Chemical compound FC(F)(F)C1=CC=C(C(=O)CBr)C=C1 HEMROKPXTCOASZ-UHFFFAOYSA-N 0.000 description 1
- WPDWOCRJBPXJFM-UHFFFAOYSA-N 2-bromo-1-phenylpropan-1-one Chemical compound CC(Br)C(=O)C1=CC=CC=C1 WPDWOCRJBPXJFM-UHFFFAOYSA-N 0.000 description 1
- DNPMOGQMEOPVNT-UHFFFAOYSA-N 2-bromo-1-pyridin-2-ylethanone Chemical compound BrCC(=O)C1=CC=CC=N1 DNPMOGQMEOPVNT-UHFFFAOYSA-N 0.000 description 1
- IQMGXSROJBYCLS-UHFFFAOYSA-N 2-bromo-1-pyridin-3-ylethanone Chemical compound BrCC(=O)C1=CC=CN=C1 IQMGXSROJBYCLS-UHFFFAOYSA-N 0.000 description 1
- NAFCUKZZHZYPKB-UHFFFAOYSA-N 2-bromo-1-pyridin-4-ylethanone Chemical compound BrCC(=O)C1=CC=NC=C1 NAFCUKZZHZYPKB-UHFFFAOYSA-N 0.000 description 1
- UXVCSPSWUNMPMT-UHFFFAOYSA-N 2-bromo-2,3-dihydroinden-1-one Chemical compound C1=CC=C2C(=O)C(Br)CC2=C1 UXVCSPSWUNMPMT-UHFFFAOYSA-N 0.000 description 1
- KDXYEWRAWRZXFT-UHFFFAOYSA-N 2-bromocyclohexan-1-one Chemical compound BrC1CCCCC1=O KDXYEWRAWRZXFT-UHFFFAOYSA-N 0.000 description 1
- UXZYKSFMGDWHGJ-UHFFFAOYSA-N 2-chloro-1-methylbenzimidazole Chemical compound C1=CC=C2N(C)C(Cl)=NC2=C1 UXZYKSFMGDWHGJ-UHFFFAOYSA-N 0.000 description 1
- QRXBTPFMCTXCRD-UHFFFAOYSA-N 2-chloropyridine-4-carbonitrile Chemical compound ClC1=CC(C#N)=CC=N1 QRXBTPFMCTXCRD-UHFFFAOYSA-N 0.000 description 1
- FFNVQNRYTPFDDP-UHFFFAOYSA-N 2-cyanopyridine Chemical compound N#CC1=CC=CC=N1 FFNVQNRYTPFDDP-UHFFFAOYSA-N 0.000 description 1
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
- TWHOWABQAGGDIK-UHFFFAOYSA-N 2-methyl-1-(5-methyl-2-phenyl-1,3-oxazol-4-yl)propan-2-amine Chemical compound CC(N)(C)CC1=C(C)OC(C=2C=CC=CC=2)=N1 TWHOWABQAGGDIK-UHFFFAOYSA-N 0.000 description 1
- LDZYRENCLPUXAX-UHFFFAOYSA-N 2-methyl-1h-benzimidazole Chemical compound C1=CC=C2NC(C)=NC2=C1 LDZYRENCLPUXAX-UHFFFAOYSA-N 0.000 description 1
- JBKCUDFGQAGECF-UHFFFAOYSA-N 2-methyl-2-n-(5-phenyl-1,3,4-oxadiazol-2-yl)propane-1,2-diamine Chemical compound O1C(NC(C)(CN)C)=NN=C1C1=CC=CC=C1 JBKCUDFGQAGECF-UHFFFAOYSA-N 0.000 description 1
- HNTZKNJGAFJMHQ-UHFFFAOYSA-N 2-methylpyridine-3-carboxylic acid Chemical compound CC1=NC=CC=C1C(O)=O HNTZKNJGAFJMHQ-UHFFFAOYSA-N 0.000 description 1
- FGLBSLMDCBOPQK-UHFFFAOYSA-N 2-nitropropane Chemical compound CC(C)[N+]([O-])=O FGLBSLMDCBOPQK-UHFFFAOYSA-N 0.000 description 1
- 125000003504 2-oxazolinyl group Chemical class O1C(=NCC1)* 0.000 description 1
- KLLLJCACIRKBDT-UHFFFAOYSA-N 2-phenyl-1H-indole Chemical compound N1C2=CC=CC=C2C=C1C1=CC=CC=C1 KLLLJCACIRKBDT-UHFFFAOYSA-N 0.000 description 1
- YMMHAIJRFWRDMG-UHFFFAOYSA-N 3,4,4a,5-tetrahydro-1h-quinolin-2-one Chemical compound C1C=CC=C2NC(=O)CCC21 YMMHAIJRFWRDMG-UHFFFAOYSA-N 0.000 description 1
- PUJSUOGJGIECFQ-UHFFFAOYSA-N 3,5-dichlorobenzonitrile Chemical compound ClC1=CC(Cl)=CC(C#N)=C1 PUJSUOGJGIECFQ-UHFFFAOYSA-N 0.000 description 1
- QCCACCYICHJVIN-UHFFFAOYSA-N 3,5-difluorobenzenecarboximidamide;hydron;chloride Chemical compound Cl.NC(=N)C1=CC(F)=CC(F)=C1 QCCACCYICHJVIN-UHFFFAOYSA-N 0.000 description 1
- YTLRWVNYANKXOW-UHFFFAOYSA-N 3,5-dimethoxybenzamide Chemical compound COC1=CC(OC)=CC(C(N)=O)=C1 YTLRWVNYANKXOW-UHFFFAOYSA-N 0.000 description 1
- JYCNBCYWSLQCFS-UHFFFAOYSA-N 3,5-dimethoxybenzenecarboximidamide;hydrochloride Chemical compound Cl.COC1=CC(OC)=CC(C(N)=N)=C1 JYCNBCYWSLQCFS-UHFFFAOYSA-N 0.000 description 1
- JJLMOUMOJSUSSX-UHFFFAOYSA-N 3-(1h-pyrazol-5-yl)pyridine Chemical compound N1N=CC=C1C1=CC=CN=C1 JJLMOUMOJSUSSX-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- CRTCNWBTASZQFC-UHFFFAOYSA-N 3-(2-methyl-1h-imidazol-5-yl)pyridine Chemical compound N1C(C)=NC(C=2C=NC=CC=2)=C1 CRTCNWBTASZQFC-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- HVIMOBDITJFPGV-UHFFFAOYSA-N 3-(5-methyl-1h-1,2,4-triazol-3-yl)pyridine Chemical compound N1C(C)=NC(C=2C=NC=CC=2)=N1 HVIMOBDITJFPGV-UHFFFAOYSA-N 0.000 description 1
- MESJRHHDBDCQTH-UHFFFAOYSA-N 3-(dimethylamino)phenol Chemical compound CN(C)C1=CC=CC(O)=C1 MESJRHHDBDCQTH-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- GQGPVCFZHXGKNK-UHFFFAOYSA-N 3-[5-(trifluoromethyl)-1h-1,2,4-triazol-3-yl]pyridine Chemical compound N1C(C(F)(F)F)=NC(C=2C=NC=CC=2)=N1 GQGPVCFZHXGKNK-UHFFFAOYSA-N 0.000 description 1
- HLZNBWOEBYXDEO-UHFFFAOYSA-N 3-[5-(trifluoromethyl)-1h-pyrazol-3-yl]pyridine Chemical compound N1C(C(F)(F)F)=CC(C=2C=NC=CC=2)=N1 HLZNBWOEBYXDEO-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- XNHDJBJSICAZMR-UHFFFAOYSA-N 3-bromo-1-phenylpropane-1,2-dione Chemical compound BrCC(=O)C(=O)C1=CC=CC=C1 XNHDJBJSICAZMR-UHFFFAOYSA-N 0.000 description 1
- BNBOUFHCTIFWHN-UHFFFAOYSA-N 3-bromobutan-2-one Chemical compound CC(Br)C(C)=O BNBOUFHCTIFWHN-UHFFFAOYSA-N 0.000 description 1
- MLQSDZDFNFPEOK-UHFFFAOYSA-N 3-ethoxybenzenecarboximidamide;hydrochloride Chemical compound Cl.CCOC1=CC=CC(C(N)=N)=C1 MLQSDZDFNFPEOK-UHFFFAOYSA-N 0.000 description 1
- VXAQJXKADWRKGS-UHFFFAOYSA-N 3-fluoro-4-methylbenzenecarboximidamide;hydrochloride Chemical compound [Cl-].CC1=CC=C(C(N)=[NH2+])C=C1F VXAQJXKADWRKGS-UHFFFAOYSA-N 0.000 description 1
- DEDJQZNLAXYJBT-UHFFFAOYSA-N 3-methylpyrazine-2-carboxylic acid Chemical compound CC1=NC=CN=C1C(O)=O DEDJQZNLAXYJBT-UHFFFAOYSA-N 0.000 description 1
- LMHIBYREWJHKNZ-UHFFFAOYSA-N 3-methylpyridine-2-carboxylic acid Chemical compound CC1=CC=CN=C1C(O)=O LMHIBYREWJHKNZ-UHFFFAOYSA-N 0.000 description 1
- OSMAGAVKVRGYGR-UHFFFAOYSA-N 3-methylpyridine-4-carboxylic acid Chemical compound CC1=CN=CC=C1C(O)=O OSMAGAVKVRGYGR-UHFFFAOYSA-N 0.000 description 1
- IFLKEBSJTZGCJG-UHFFFAOYSA-N 3-methylthiophene-2-carboxylic acid Chemical compound CC=1C=CSC=1C(O)=O IFLKEBSJTZGCJG-UHFFFAOYSA-N 0.000 description 1
- KJKWJOAARUHGNU-UHFFFAOYSA-N 3-phenyl-5-(trifluoromethyl)-1h-pyrazole Chemical compound N1C(C(F)(F)F)=CC(C=2C=CC=CC=2)=N1 KJKWJOAARUHGNU-UHFFFAOYSA-N 0.000 description 1
- GZPHSAQLYPIAIN-UHFFFAOYSA-N 3-pyridinecarbonitrile Chemical compound N#CC1=CC=CN=C1 GZPHSAQLYPIAIN-UHFFFAOYSA-N 0.000 description 1
- PHLHCPVLMADSPK-UHFFFAOYSA-N 4-(2-azidoethyl)-5-methyl-2-phenyl-1,3-oxazole 2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethanol Chemical compound CC1=C(N=C(O1)C1=CC=CC=C1)CCO.N(=[N+]=[N-])CCC=1N=C(OC1C)C1=CC=CC=C1 PHLHCPVLMADSPK-UHFFFAOYSA-N 0.000 description 1
- XKKIWFIAVAHRQS-UHFFFAOYSA-N 4-(2-bromopropanoyl)benzonitrile Chemical compound CC(Br)C(=O)C1=CC=C(C#N)C=C1 XKKIWFIAVAHRQS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- IAKHDTQJFDTTSR-UHFFFAOYSA-N 4-(chloromethyl)-2-(3-chlorophenyl)-5-methyl-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=C(Cl)C=CC=2)=N1 IAKHDTQJFDTTSR-UHFFFAOYSA-N 0.000 description 1
- SVEGSFSFMLCNFF-UHFFFAOYSA-N 4-(chloromethyl)-2-phenyl-1,3-thiazole Chemical compound ClCC1=CSC(C=2C=CC=CC=2)=N1 SVEGSFSFMLCNFF-UHFFFAOYSA-N 0.000 description 1
- WFNBXZSZIBQEFF-UHFFFAOYSA-N 4-(chloromethyl)-2-piperidin-1-yl-1,3-thiazole Chemical compound ClCC1=CSC(N2CCCCC2)=N1 WFNBXZSZIBQEFF-UHFFFAOYSA-N 0.000 description 1
- CZFJTOSWONKWDN-UHFFFAOYSA-N 4-(chloromethyl)-5-methyl-2-(3-methylphenyl)-1,3-oxazole Chemical compound ClCC1=C(C)OC(C=2C=C(C)C=CC=2)=N1 CZFJTOSWONKWDN-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- SVLZRCRXNHITBY-UHFFFAOYSA-N 4-chloro-1h-indole Chemical compound ClC1=CC=CC2=C1C=CN2 SVLZRCRXNHITBY-UHFFFAOYSA-N 0.000 description 1
- BLNVISNJTIRAHF-UHFFFAOYSA-N 4-chlorobenzamide Chemical compound NC(=O)C1=CC=C(Cl)C=C1 BLNVISNJTIRAHF-UHFFFAOYSA-N 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- JIZAZPRNIWVYAX-UHFFFAOYSA-N 4-fluoro-3-methylbenzamide Chemical compound CC1=CC(C(N)=O)=CC=C1F JIZAZPRNIWVYAX-UHFFFAOYSA-N 0.000 description 1
- GUCPYIYFQVTFSI-UHFFFAOYSA-N 4-methoxybenzamide Chemical compound COC1=CC=C(C(N)=O)C=C1 GUCPYIYFQVTFSI-UHFFFAOYSA-N 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- QODBZRNBPUPLEZ-UHFFFAOYSA-N 5,6-dimethoxy-1h-indole Chemical compound C1=C(OC)C(OC)=CC2=C1NC=C2 QODBZRNBPUPLEZ-UHFFFAOYSA-N 0.000 description 1
- KPLGJLRESZZWIX-UHFFFAOYSA-N 5-(2-methyl-2-nitropropyl)-2-phenyl-1h-imidazole Chemical compound [O-][N+](=O)C(C)(C)CC1=CNC(C=2C=CC=CC=2)=N1 KPLGJLRESZZWIX-UHFFFAOYSA-N 0.000 description 1
- JOSYKZQNBMKHRX-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1h-1,2,4-triazole Chemical compound C1=CC(OC)=CC=C1C1=NNC=N1 JOSYKZQNBMKHRX-UHFFFAOYSA-N 0.000 description 1
- QUSABYOAMXPMQH-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1h-pyrazole Chemical compound C1=CC(OC)=CC=C1C1=CC=NN1 QUSABYOAMXPMQH-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- BJUZAZKEDCDGRW-UHFFFAOYSA-N 5-bromo-2-methyl-1h-indole Chemical compound BrC1=CC=C2NC(C)=CC2=C1 BJUZAZKEDCDGRW-UHFFFAOYSA-N 0.000 description 1
- ZYMHCFYHVYGFMS-UHFFFAOYSA-N 5-methyl-1,3-oxazole Chemical compound CC1=CN=CO1 ZYMHCFYHVYGFMS-UHFFFAOYSA-N 0.000 description 1
- DPKRQNPVMPJPBH-UHFFFAOYSA-N 5-methyl-3-[3-(trifluoromethyl)phenyl]-1h-pyrazole Chemical compound N1C(C)=CC(C=2C=C(C=CC=2)C(F)(F)F)=N1 DPKRQNPVMPJPBH-UHFFFAOYSA-N 0.000 description 1
- UJCLXNPHJKRLPX-UHFFFAOYSA-N 5-methyl-3-phenyl-1h-1,2,4-triazole Chemical compound N1C(C)=NC(C=2C=CC=CC=2)=N1 UJCLXNPHJKRLPX-UHFFFAOYSA-N 0.000 description 1
- TXZWTBWOSYUGPN-UHFFFAOYSA-N 5-methyl-4-(2-methyl-2-nitropropyl)-2-phenyl-1h-imidazole Chemical compound [O-][N+](=O)C(C)(C)CC1=C(C)NC(C=2C=CC=CC=2)=N1 TXZWTBWOSYUGPN-UHFFFAOYSA-N 0.000 description 1
- XHLKOHSAWQPOFO-UHFFFAOYSA-N 5-phenyl-1h-imidazole Chemical compound N1C=NC=C1C1=CC=CC=C1 XHLKOHSAWQPOFO-UHFFFAOYSA-N 0.000 description 1
- OEDUIFSDODUDRK-UHFFFAOYSA-N 5-phenyl-1h-pyrazole Chemical compound N1N=CC=C1C1=CC=CC=C1 OEDUIFSDODUDRK-UHFFFAOYSA-N 0.000 description 1
- OTLWHHHZQLDXEK-UHFFFAOYSA-N 5-phenyl-2,3-dihydro-1h-indole Chemical compound C=1C=C2NCCC2=CC=1C1=CC=CC=C1 OTLWHHHZQLDXEK-UHFFFAOYSA-N 0.000 description 1
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- AOZHIRVTXWVRCY-UHFFFAOYSA-N 6-(4-methoxyphenyl)-1h-indole Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C=CN2)C2=C1 AOZHIRVTXWVRCY-UHFFFAOYSA-N 0.000 description 1
- MAWGHOPSCKCTPA-UHFFFAOYSA-N 6-bromo-1h-indole Chemical compound BrC1=CC=C2C=CNC2=C1 MAWGHOPSCKCTPA-UHFFFAOYSA-N 0.000 description 1
- WASIYUSITZITPW-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine Chemical compound C1C(N)CCC2=CC(OC)=CC=C21 WASIYUSITZITPW-UHFFFAOYSA-N 0.000 description 1
- RMRKDYNVZWKAFP-UHFFFAOYSA-N 6-methoxy-3,4-dihydro-1h-naphthalen-2-one Chemical compound C1C(=O)CCC2=CC(OC)=CC=C21 RMRKDYNVZWKAFP-UHFFFAOYSA-N 0.000 description 1
- PBLOYQAQGYUPCM-UHFFFAOYSA-N 6-methylpyridine-3-carbonitrile Chemical compound CC1=CC=C(C#N)C=N1 PBLOYQAQGYUPCM-UHFFFAOYSA-N 0.000 description 1
- RDSVSEFWZUWZHW-UHFFFAOYSA-N 7-bromo-1h-indole Chemical compound BrC1=CC=CC2=C1NC=C2 RDSVSEFWZUWZHW-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229910000838 Al alloy Inorganic materials 0.000 description 1
- 229920003084 Avicel® PH-102 Polymers 0.000 description 1
- OFEGAJROTABNNR-UHFFFAOYSA-N Br.BrCC(=O)C1=NC=CC=C1.CC=1NC=C(N1)C=1C=NC=CC1 Chemical compound Br.BrCC(=O)C1=NC=CC=C1.CC=1NC=C(N1)C=1C=NC=CC1 OFEGAJROTABNNR-UHFFFAOYSA-N 0.000 description 1
- NVHVCDZZIRRZGY-UHFFFAOYSA-N CCOC(C)=O.Cc1cc(n[nH]1)-c1cccc(c1)C(F)(F)F Chemical compound CCOC(C)=O.Cc1cc(n[nH]1)-c1cccc(c1)C(F)(F)F NVHVCDZZIRRZGY-UHFFFAOYSA-N 0.000 description 1
- XHAMZVVAHJVIAD-UHFFFAOYSA-N COClC#N Chemical group COClC#N XHAMZVVAHJVIAD-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010011416 Croup infectious Diseases 0.000 description 1
- 238000006969 Curtius rearrangement reaction Methods 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 description 1
- 240000001414 Eucalyptus viminalis Species 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 1
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- QEPOBSOBJMMKRJ-UHFFFAOYSA-N O.NN.FC(C1=NC(=NN1)C=1C=NC=CC1)(F)F Chemical compound O.NN.FC(C1=NC(=NN1)C=1C=NC=CC1)(F)F QEPOBSOBJMMKRJ-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000003800 Staudinger reaction Methods 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930182558 Sterol Chemical class 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- STSCVKRWJPWALQ-UHFFFAOYSA-N TRIFLUOROACETIC ACID ETHYL ESTER Chemical compound CCOC(=O)C(F)(F)F STSCVKRWJPWALQ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- ZJJRYYDAAUVIFH-UHFFFAOYSA-N [1-[2-(3-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]-2-methylpropan-2-yl]carbamic acid Chemical compound OC(=O)NC(C)(C)CC1=C(C)OC(C=2C=C(Cl)C=CC=2)=N1 ZJJRYYDAAUVIFH-UHFFFAOYSA-N 0.000 description 1
- OPCYYFDERBISMA-UHFFFAOYSA-N [2-(3-chloro-4-methylphenyl)-5-methyl-1h-imidazol-4-yl]methanol;hydrochloride Chemical compound Cl.OCC1=C(C)NC(C=2C=C(Cl)C(C)=CC=2)=N1 OPCYYFDERBISMA-UHFFFAOYSA-N 0.000 description 1
- VWFPJKFMLVUSAC-UHFFFAOYSA-N [2-(3-fluoro-4-methylphenyl)-5-methyl-1h-imidazol-4-yl]methanol Chemical compound OCC1=C(C)NC(C=2C=C(F)C(C)=CC=2)=N1 VWFPJKFMLVUSAC-UHFFFAOYSA-N 0.000 description 1
- RPYRNRDCPXFHCM-UHFFFAOYSA-N [2-(4-chlorophenyl)-5-methyl-1h-imidazol-4-yl]methanol;hydrochloride Chemical compound Cl.OCC1=C(C)NC(C=2C=CC(Cl)=CC=2)=N1 RPYRNRDCPXFHCM-UHFFFAOYSA-N 0.000 description 1
- ALMFIOZYDASRRC-UHFFFAOYSA-N [4-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=C(C(F)(F)F)C=C1 ALMFIOZYDASRRC-UHFFFAOYSA-N 0.000 description 1
- RZKXVTVMFHVPTJ-UHFFFAOYSA-N [5-methyl-2-(4-methylphenyl)-1h-imidazol-4-yl]methanol;hydrochloride Chemical compound Cl.OCC1=C(C)NC(C=2C=CC(C)=CC=2)=N1 RZKXVTVMFHVPTJ-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 238000005571 anion exchange chromatography Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- MXOQNVMDKHLYCZ-UHFFFAOYSA-N benzamidoxime Chemical compound ON=C(N)C1=CC=CC=C1 MXOQNVMDKHLYCZ-UHFFFAOYSA-N 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 229940045348 brown mixture Drugs 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000005277 cation exchange chromatography Methods 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WBLIXGSTEMXDSM-UHFFFAOYSA-N chloromethane Chemical compound Cl[CH2] WBLIXGSTEMXDSM-UHFFFAOYSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010549 croup Diseases 0.000 description 1
- YSSSPARMOAYJTE-UHFFFAOYSA-N dibenzo-18-crown-6 Chemical compound O1CCOCCOC2=CC=CC=C2OCCOCCOC2=CC=CC=C21 YSSSPARMOAYJTE-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- WCQOBLXWLRDEQA-UHFFFAOYSA-N ethanimidamide;hydrochloride Chemical compound Cl.CC(N)=N WCQOBLXWLRDEQA-UHFFFAOYSA-N 0.000 description 1
- VCYZVXRKYPKDQB-UHFFFAOYSA-N ethyl 2-fluoroacetate Chemical compound CCOC(=O)CF VCYZVXRKYPKDQB-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004675 formic acid derivatives Chemical class 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 150000002476 indolines Chemical class 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960004903 invert sugar Drugs 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000004969 ion scattering spectroscopy Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- JXNKMKANQORTNN-UHFFFAOYSA-N n-(3,4-dihydro-1h-naphthalen-2-ylidene)hydroxylamine Chemical compound C1=CC=C2CC(=NO)CCC2=C1 JXNKMKANQORTNN-UHFFFAOYSA-N 0.000 description 1
- WOJISTHIFAOREU-UHFFFAOYSA-N n-(3-methanehydrazonoylphenyl)acetamide Chemical compound CC(=O)NC1=CC=CC(C=NN)=C1 WOJISTHIFAOREU-UHFFFAOYSA-N 0.000 description 1
- FNWANZVQXBSPSJ-UHFFFAOYSA-N n-[(z)-[amino(pyridin-3-yl)methylidene]amino]-2,2,2-trifluoroacetamide Chemical compound FC(F)(F)C(=O)N\N=C(/N)C1=CC=CN=C1 FNWANZVQXBSPSJ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004780 naphthols Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229920001223 polyethylene glycol Chemical class 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003147 proline derivatives Chemical class 0.000 description 1
- UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical compound CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- OHFIJHDYYOCZME-UHFFFAOYSA-N pyrazine-2-carbohydrazide Chemical compound NNC(=O)C1=CN=CC=N1 OHFIJHDYYOCZME-UHFFFAOYSA-N 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- GPHQHTOMRSGBNZ-UHFFFAOYSA-N pyridine-4-carbonitrile Chemical compound N#CC1=CC=NC=C1 GPHQHTOMRSGBNZ-UHFFFAOYSA-N 0.000 description 1
- 150000003235 pyrrolidines Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- KHAVKEAKEFLGHG-UHFFFAOYSA-N tert-butyl 2,2-dimethyl-4-oxoazetidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1C(=O)CC1(C)C KHAVKEAKEFLGHG-UHFFFAOYSA-N 0.000 description 1
- XDJCYKMWJCYQJM-UHFFFAOYSA-N tert-butyl n-(3-hydroxypropyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCO XDJCYKMWJCYQJM-UHFFFAOYSA-N 0.000 description 1
- QHSUFODBDZQCHO-UHFFFAOYSA-N tert-butyl n-(4-hydroxy-2-methylbutan-2-yl)carbamate Chemical compound CC(C)(C)OC(=O)NC(C)(C)CCO QHSUFODBDZQCHO-UHFFFAOYSA-N 0.000 description 1
- KDYYLEUARJTNMU-UHFFFAOYSA-N tert-butyl n-[2-methyl-4-(3-methyl-5-pyridin-3-ylpyrazol-1-yl)butan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC(C)(C)CCN1N=C(C)C=C1C1=CC=CN=C1 KDYYLEUARJTNMU-UHFFFAOYSA-N 0.000 description 1
- NOLQTTOLVAUKMM-UHFFFAOYSA-N tert-butyl n-[2-methyl-4-(5-methyl-3-phenylpyrazol-1-yl)butan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC(C)(C)CCN1C(C)=CC(C=2C=CC=CC=2)=N1 NOLQTTOLVAUKMM-UHFFFAOYSA-N 0.000 description 1
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Botany (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01125338 | 2001-10-26 | ||
EP02018227 | 2002-08-21 | ||
PCT/EP2002/011711 WO2003037327A1 (fr) | 2001-10-26 | 2002-10-18 | Derives de pyrrolidine n-substitues en tant qu'inhibiteurs de la dipeptidyl peptidase iv |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20040344A2 true HRP20040344A2 (en) | 2005-02-28 |
Family
ID=26076751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20040344A HRP20040344A2 (en) | 2001-10-26 | 2004-04-15 | N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors |
Country Status (27)
Country | Link |
---|---|
US (3) | US6861440B2 (fr) |
EP (1) | EP1441719B1 (fr) |
JP (1) | JP4171417B2 (fr) |
KR (1) | KR100645671B1 (fr) |
CN (1) | CN1713907B (fr) |
AR (1) | AR036958A1 (fr) |
AT (1) | ATE503477T1 (fr) |
AU (1) | AU2002338902B2 (fr) |
BR (1) | BR0213539A (fr) |
CA (1) | CA2463709C (fr) |
DE (1) | DE60239629D1 (fr) |
EA (1) | EA007968B1 (fr) |
GT (2) | GT200200220AA (fr) |
HR (1) | HRP20040344A2 (fr) |
HU (1) | HUP0402107A3 (fr) |
IL (2) | IL161158A0 (fr) |
MA (1) | MA26342A1 (fr) |
MX (1) | MXPA04003759A (fr) |
NO (1) | NO20041709L (fr) |
NZ (1) | NZ531942A (fr) |
PA (1) | PA8557001A1 (fr) |
PE (1) | PE20030704A1 (fr) |
PL (1) | PL370551A1 (fr) |
TN (1) | TNSN04073A1 (fr) |
UY (1) | UY27518A1 (fr) |
WO (1) | WO2003037327A1 (fr) |
YU (1) | YU34404A (fr) |
Families Citing this family (148)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60222667T2 (de) | 2001-06-27 | 2008-07-17 | Smithkline Beecham Corp. | Fluorpyrrolidine als dipeptidylpeptidaseinhibitoren |
GB0125445D0 (en) * | 2001-10-23 | 2001-12-12 | Ferring Bv | Protease Inhibitors |
US6861440B2 (en) * | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
JP2005170792A (ja) * | 2002-11-22 | 2005-06-30 | Mitsubishi Pharma Corp | L−プロリン誘導体およびその医薬としての用途。 |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
CN100434420C (zh) * | 2003-01-31 | 2008-11-19 | 株式会社三和化学研究所 | 阻碍二肽基肽酶ⅳ的化合物 |
JP4887139B2 (ja) | 2003-03-25 | 2012-02-29 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼインヒビター |
JP4806628B2 (ja) | 2003-05-05 | 2011-11-02 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤 |
EP1625122A1 (fr) | 2003-05-14 | 2006-02-15 | Takeda San Diego, Inc. | Inhibiteurs de dipeptidyl peptidase |
EP1635818B1 (fr) * | 2003-06-06 | 2010-04-07 | Merck Sharp & Dohme Corp. | Indoles fusionnes en tant qu'inhibiteurs de dipeptidyle peptidase destines au traitement ou a la prevention des diabetes |
PT1638970E (pt) * | 2003-06-20 | 2010-12-13 | Hoffmann La Roche | Derivados de pirid(2,1-a)isoquinolina como inibidores de dpp-iv |
DE602004010206T2 (de) | 2003-08-13 | 2008-10-09 | Takeda Pharmaceutical Co. Ltd. | Dipeptidyl Peptidase Inhibitoren. |
US7169926B1 (en) | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US7678909B1 (en) | 2003-08-13 | 2010-03-16 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
JP2007505121A (ja) | 2003-09-08 | 2007-03-08 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
EP1697342A2 (fr) * | 2003-09-08 | 2006-09-06 | Takeda Pharmaceutical Company Limited | Inhibiteurs de dipeptidyle peptidase |
AU2004290499C1 (en) | 2003-11-03 | 2011-02-24 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
KR20150028829A (ko) | 2003-11-17 | 2015-03-16 | 노파르티스 아게 | 디펩티딜 펩티다제 ⅳ 억제제의 용도 |
BRPI0507007A (pt) | 2004-01-20 | 2007-06-05 | Novartis Ag | formulação e processo de compressão direta |
US7230002B2 (en) | 2004-02-03 | 2007-06-12 | Glenmark Pharmaceuticals Ltd. | Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof |
CA2554809C (fr) | 2004-02-05 | 2014-04-29 | Probiodrug Ag | Nouveaux inhibiteurs de la glutaminyl-cyclase comportant de la n thiouree alkyle et de l'imidazolyl substitue par thioamide |
US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
US7687504B2 (en) | 2004-03-09 | 2010-03-30 | National Health Research Institutes | Pyrrolidine compounds |
US7732446B1 (en) | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
CA2559302C (fr) | 2004-03-15 | 2012-06-19 | Takeda Pharmaceutical Company Limited | Inhibiteurs de la dipeptidyle peptidase |
US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
WO2005108382A1 (fr) * | 2004-05-04 | 2005-11-17 | Merck & Co., Inc. | Derives de 1,2,4-oxadiazole en tant qu'inhibiteurs de la dipeptidylpeptidase-iv dans le traitement ou la prevention de diabetes |
US7687638B2 (en) | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
WO2006019965A2 (fr) | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Inhibiteurs de la dipeptidyl peptidase |
EP1794120B1 (fr) | 2004-07-23 | 2012-04-11 | Nuada, LLC | Inhibiteurs de peptidase |
FR2873694B1 (fr) * | 2004-07-27 | 2006-12-08 | Merck Sante Soc Par Actions Si | Nouveaux aza-indoles inhibiteurs de la mtp et apob |
AP2007003973A0 (en) | 2004-10-12 | 2007-07-30 | Glenmark Pharmaceuticals Sa | Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
JP2008524331A (ja) | 2004-12-21 | 2008-07-10 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼ阻害剤 |
DOP2006000008A (es) * | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
WO2006100181A2 (fr) | 2005-03-22 | 2006-09-28 | F. Hoffmann-La Roche Ag | Nouveau sel et polymorphes de l'inhibiteur de dpp-iv |
TWI357902B (en) | 2005-04-01 | 2012-02-11 | Lg Life Science Ltd | Dipeptidyl peptidase-iv inhibiting compounds, meth |
CN101277949A (zh) * | 2005-04-22 | 2008-10-01 | 阿兰托斯制药控股公司 | 二肽基肽酶-ⅳ抑制剂 |
MY152185A (en) | 2005-06-10 | 2014-08-29 | Novartis Ag | Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
US7807840B2 (en) | 2005-06-28 | 2010-10-05 | Fujimoto Co., Ltd. | Process for preparing optically active aminopentane derivative, intermediate and process for preparing intermediate |
US8106090B2 (en) | 2005-07-20 | 2012-01-31 | Eli Lilly And Company | 1-amino linked compounds |
CA2616937A1 (fr) | 2005-07-29 | 2007-02-08 | F. Hoffman-La Roche Ag | Derives de indol-3-yl-carbonyl-piperidine et piperazine |
DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
AU2006278039B2 (en) * | 2005-08-11 | 2010-10-21 | F. Hoffmann-La Roche Ag | Pharmaceutical composition comprising a DPP-lV inhibitor |
PT1942898E (pt) * | 2005-09-14 | 2011-12-20 | Takeda Pharmaceutical | Inibidores da dipeptidilpeptidase para o tratamento da diabetes |
WO2007033266A2 (fr) * | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Administration d'inhibiteurs de dipeptidyl peptidase |
TW200745079A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
TW200745080A (en) * | 2005-09-16 | 2007-12-16 | Takeda Pharmaceuticals Co | Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor |
JP5122462B2 (ja) | 2005-09-16 | 2013-01-16 | 武田薬品工業株式会社 | ジペプチジルペプチダーゼ阻害剤 |
CA2631128A1 (fr) | 2005-12-09 | 2007-06-14 | F. Hoffmann-La Roche Ag | Derives d'amides tricycliques utiles pour le traitement de l'obesite |
ES2351471T3 (es) * | 2005-12-21 | 2011-02-07 | F. Hoffmann-La Roche Ag | Nueva sal y polimorfo de inhibidores de dpp-iv. |
GB0526291D0 (en) | 2005-12-23 | 2006-02-01 | Prosidion Ltd | Therapeutic method |
US20090156465A1 (en) | 2005-12-30 | 2009-06-18 | Sattigeri Jitendra A | Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
WO2007112347A1 (fr) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Inhibiteurs de la dipeptidyl peptidase |
WO2007112368A1 (fr) * | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Préparation de dichlorhydrate de (r)-3-aminopipéridine |
DK1971862T3 (da) * | 2006-04-11 | 2011-02-14 | Arena Pharm Inc | Fremgangsmåder til anvendelse af GPR119-receptor til identificering af forbindelser anvendelige til øgning af knoglemasse hos en person |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
CA2649209A1 (fr) | 2006-04-12 | 2007-10-18 | Probiodrug Ag | Inhibiteurs d'enzyme |
EP1852108A1 (fr) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Compositions d'inhibiteurs de la DPP IV |
NZ573360A (en) | 2006-05-04 | 2012-08-31 | Boehringer Ingelheim Int | Polymorphic forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
KR102062824B1 (ko) * | 2006-09-13 | 2020-01-07 | 다케다 야쿠힌 고교 가부시키가이샤 | 2-[6-(3-아미노-피페리딘-1-일)-3-메틸-2,4-디옥소-3,4-디하이드로-2h-피리미딘-1-일메틸]-4-플루오로-벤조니트릴의 용도 |
EP2089383B1 (fr) | 2006-11-09 | 2015-09-16 | Probiodrug AG | Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
US9656991B2 (en) | 2007-04-18 | 2017-05-23 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
US8084473B2 (en) | 2007-04-24 | 2011-12-27 | Solvay Pharmaceuticals B.V. | Heterocyclic compounds with affinity to muscarinic receptors |
JP2010525020A (ja) * | 2007-04-24 | 2010-07-22 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | ムスカリン性受容体への親和性を有する複素環式化合物 |
EP2170930B3 (fr) | 2007-06-04 | 2013-10-02 | Synergy Pharmaceuticals Inc. | Agonistes de guanylase cyclase utiles pour le traitement de troubles gastro-intestinaux, d'inflammation, de cancer et d'autres troubles |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
PE20090938A1 (es) * | 2007-08-16 | 2009-08-08 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo |
UY31290A1 (es) * | 2007-08-16 | 2009-03-31 | Composicion farmacéutica que comprende un derivado de pirazol-o-glucosido | |
GB2465132B (en) * | 2007-09-21 | 2012-06-06 | Lupin Ltd | Compounds as dipeptidyl peptidase IV (DPP IV) inhibitors |
BRPI0819719B8 (pt) * | 2007-12-21 | 2021-05-25 | Lg Chemical Ltd | compostos de inibição de dipeptidil peptidase-iv, métodos de preparação dos mesmos, e preparações farmacêuticas contendo os mesmos como agente ativo |
JP5438028B2 (ja) * | 2008-01-23 | 2014-03-12 | ジエンス ハンセン ファーマセウティカル カンパニー リミテッド | アザビシクロオクタンの誘導体、その製造方法及びそのジペプチジルペプチダーゼivの阻害剤としての用途 |
EP2252582B1 (fr) | 2008-03-05 | 2014-07-23 | National Health Research Institutes | Dérivés de pyrrolidine |
AR071175A1 (es) | 2008-04-03 | 2010-06-02 | Boehringer Ingelheim Int | Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante |
EP2108960A1 (fr) * | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Procédés d'utilisation d'un récepteur couplé à protéine G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement des conditions modulées de secrétagogues BY (PYY) et composés utiles dans le traitement des conditions par PYY |
PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
JP5906086B2 (ja) * | 2008-08-15 | 2016-04-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Fab関連疾患の治療に用いるためのプリン誘導体 |
JP2012502081A (ja) | 2008-09-10 | 2012-01-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖尿病及び関連症状の治療のための組み合わせ治療 |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
CN102264228A (zh) | 2008-10-22 | 2011-11-30 | 默沙东公司 | 用于抗糖尿病药的新的环状苯并咪唑衍生物 |
AU2009309037A1 (en) | 2008-10-31 | 2010-05-06 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
TWI508965B (zh) | 2008-12-23 | 2015-11-21 | Boehringer Ingelheim Int | 有機化合物的鹽形式 |
TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
TWI466672B (zh) | 2009-01-29 | 2015-01-01 | Boehringer Ingelheim Int | 小兒科病人糖尿病之治療 |
WO2010092125A1 (fr) | 2009-02-13 | 2010-08-19 | Boehringer Ingelheim International Gmbh | Composition pharmaceutique contenant un inhibiteur sglt-2, un inhibiteur dpp-iv et facultativement un autre agent antidiabétique et ses utilisations |
CN106177958A (zh) | 2009-02-13 | 2016-12-07 | 勃林格殷格翰国际有限公司 | 包含dpp‑4抑制剂(利拉列汀)任选地组合其它抗糖尿病药的抗糖尿病药物 |
CN101823987B (zh) * | 2009-03-06 | 2014-06-04 | 中国科学院上海药物研究所 | 一类新的dpp-ⅳ抑制剂及其制备方法和用途 |
GB2483614B (en) | 2009-06-18 | 2014-12-03 | Lupin Ltd | 2-Amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
MX2012002993A (es) | 2009-09-11 | 2012-04-19 | Probiodrug Ag | Derivados heterociclicos como inhibidores de ciclasa glutaminilo. |
JPWO2011055770A1 (ja) * | 2009-11-06 | 2013-03-28 | 武田薬品工業株式会社 | 縮合複素環化合物 |
JP2013512229A (ja) | 2009-11-27 | 2013-04-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療 |
AU2011218830B2 (en) | 2010-02-25 | 2014-07-24 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
WO2011107530A2 (fr) | 2010-03-03 | 2011-09-09 | Probiodrug Ag | Nouveaux inhibiteurs |
JP5688745B2 (ja) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤 |
WO2011113947A1 (fr) | 2010-03-18 | 2011-09-22 | Boehringer Ingelheim International Gmbh | Combinaisons d'agonistes de gpr119 et d'inhibiteurs de dpp-iv, linagliptine, pour le traitement du diabète et d'états apparentés |
MX2012011631A (es) | 2010-04-06 | 2013-01-18 | Arena Pharm Inc | Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo. |
EP2560953B1 (fr) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibiteurs de glutaminyl cyclase |
NZ602921A (en) | 2010-05-05 | 2016-01-29 | Boehringer Ingelheim Int | Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor |
MX2012014247A (es) | 2010-06-24 | 2013-01-18 | Boehringer Ingelheim Int | Terapia para la diabetes. |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
US10894787B2 (en) | 2010-09-22 | 2021-01-19 | Arena Pharmaceuticals, Inc. | Modulators of the GPR119 receptor and the treatment of disorders related thereto |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
PE20140859A1 (es) | 2011-02-25 | 2014-07-25 | Merck Sharp & Dohme | Novedosos derivados de azabencimidazol ciclico utiles como agentes antidiabeticos |
UY33937A (es) | 2011-03-07 | 2012-09-28 | Boehringer Ingelheim Int | Composiciones farmacéuticas que contienen inhibidores de dpp-4 y/o sglt-2 y metformina |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
US20140066369A1 (en) | 2011-04-19 | 2014-03-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
US20140038889A1 (en) | 2011-04-22 | 2014-02-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145604A1 (fr) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci |
WO2012170702A1 (fr) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci |
EP3517539B1 (fr) | 2011-07-15 | 2022-12-14 | Boehringer Ingelheim International GmbH | Dérivé de quinazoline dimère substitué, sa préparation et son utilisation dans des compositions pharmaceutiques pour le traitement du diabète de type i et ii |
EP2574607A1 (fr) | 2011-09-06 | 2013-04-03 | F. Hoffmann-La Roche AG | Modulateurs PDE10 |
WO2013055910A1 (fr) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulateurs du récepteur gpr119 et traitement de troubles associés |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
WO2013171167A1 (fr) | 2012-05-14 | 2013-11-21 | Boehringer Ingelheim International Gmbh | Dérivé de xanthine en tant qu'inhibiteur de dpp-4 pour l'utilisation dans le traitement de troubles associés aux podocytes et/ou un syndrome néphrotique |
WO2013174767A1 (fr) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires |
JP2015525782A (ja) | 2012-08-02 | 2015-09-07 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病性三環式化合物 |
TWI500613B (zh) | 2012-10-17 | 2015-09-21 | Cadila Healthcare Ltd | 新穎之雜環化合物 |
WO2014074668A1 (fr) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulateurs de gpr119 et traitement de troubles associés à ceux-ci |
EP2958562A4 (fr) | 2013-02-22 | 2016-08-10 | Merck Sharp & Dohme | Composés bicycliques antidiabétiques |
US9650375B2 (en) | 2013-03-14 | 2017-05-16 | Merck Sharp & Dohme Corp. | Indole derivatives useful as anti-diabetic agents |
CA2905435A1 (fr) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions utiles pour le traitement de troubles gastro-intestinaux |
WO2014151206A1 (fr) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonistes de la guanylate cyclase et leurs utilisations |
EP3004138B1 (fr) | 2013-06-05 | 2024-03-13 | Bausch Health Ireland Limited | Agonistes ultra-purs de guanylate cyclase c, leur procédé de production et d'utilisation |
WO2015051496A1 (fr) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Composés tricycliques antidiabétiques |
US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
AR100137A1 (es) * | 2014-04-22 | 2016-09-14 | Hoffmann La Roche | Compuestos 4-amino-imidazoquinolina |
CN103922965B (zh) * | 2014-04-28 | 2016-08-24 | 西安瑞联新材料股份有限公司 | 一种4-甲氧基-2-甲基苯乙腈的合成方法 |
GB201415598D0 (en) | 2014-09-03 | 2014-10-15 | Univ Birmingham | Elavated Itercranial Pressure Treatment |
KR102457848B1 (ko) * | 2014-09-17 | 2022-10-25 | 셀젠 카르 엘엘씨 | Mk2 억제제 및 이의 용도 |
CN107683135A (zh) | 2015-03-09 | 2018-02-09 | 因特克林医疗有限公司 | 用于治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法 |
EP3468562A1 (fr) | 2016-06-10 | 2019-04-17 | Boehringer Ingelheim International GmbH | Combinaisons de linagliptine et de metformine |
EP3551176A4 (fr) | 2016-12-06 | 2020-06-24 | Merck Sharp & Dohme Corp. | Composés hétérocycliques antidiabétiques |
EP3558298A4 (fr) | 2016-12-20 | 2020-08-05 | Merck Sharp & Dohme Corp. | Composés de spirochromane antidiabétiques |
SG11201909046XA (en) | 2017-04-03 | 2019-10-30 | Coherus Biosciences Inc | PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY |
ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
IL275333B2 (en) | 2017-12-15 | 2023-09-01 | Praxis Biotech LLC | Inhibitors of fibroblast activation protein |
CN112920053B (zh) * | 2021-02-01 | 2022-07-01 | 暨明医药科技(苏州)有限公司 | 一种手性α-甲基芳乙胺的制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2725386A (en) * | 1953-02-13 | 1955-11-29 | Fond Emanuele Paterno | 2-(1, 4-benzodioxan) methyl derivatives of amino-lower fatty acid amides and preparation thereof |
US5681956A (en) | 1990-12-28 | 1997-10-28 | Neurogen Corporation | 4-aryl substituted piperazinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands |
GB9313913D0 (en) | 1993-07-06 | 1993-08-18 | Smithkline Beecham Plc | Novel compounds |
US5455351A (en) * | 1993-12-13 | 1995-10-03 | Abbott Laboratories | Retroviral protease inhibiting piperazine compounds |
WO1996018681A1 (fr) * | 1994-12-14 | 1996-06-20 | Du Pont-Mitsui Polychemicals Co., Ltd. | Composition de resine thermoplastique et son utilisation |
DE19616486C5 (de) | 1996-04-25 | 2016-06-30 | Royalty Pharma Collection Trust | Verfahren zur Senkung des Blutglukosespiegels in Säugern |
TW492957B (en) | 1996-11-07 | 2002-07-01 | Novartis Ag | N-substituted 2-cyanopyrrolidnes |
US6011155A (en) * | 1996-11-07 | 2000-01-04 | Novartis Ag | N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
EP1052994A2 (fr) | 1998-02-02 | 2000-11-22 | Trustees Of Tufts College | Procede de regulation du metabolisme du glucose et reactifs afferents |
DE19834591A1 (de) | 1998-07-31 | 2000-02-03 | Probiodrug Ges Fuer Arzneim | Verfahren zur Steigerung des Blutglukosespiegels in Säugern |
GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
US6112949A (en) * | 1998-09-28 | 2000-09-05 | Robert V. Rhodes | Dual cap dispenser |
CO5150173A1 (es) | 1998-12-10 | 2002-04-29 | Novartis Ag | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv |
US6110949A (en) * | 1999-06-24 | 2000-08-29 | Novartis Ag | N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV |
AU6875800A (en) | 1999-09-10 | 2001-04-17 | Takeda Chemical Industries Ltd. | Heterocyclic compounds and process for the preparation thereof |
WO2001034594A1 (fr) | 1999-11-12 | 2001-05-17 | Guilford Pharmaceuticals, Inc. | Inhibiteurs de la dipeptidyl peptidase iv; methodes de fabrication et d'utilisation desdits inhibiteurs |
GB9928330D0 (en) | 1999-11-30 | 2000-01-26 | Ferring Bv | Novel antidiabetic agents |
WO2001055105A1 (fr) | 2000-01-24 | 2001-08-02 | Novo Nordisk A/S | 2-cyanopyroles et -pyrrolines a substitution n inhibant l'enzyme dpp-iv |
JP2003523396A (ja) | 2000-02-25 | 2003-08-05 | ノボ ノルディスク アクティーゼルスカブ | ベータ細胞変性の抑制 |
EP1323710B1 (fr) | 2000-10-06 | 2008-09-10 | Mitsubishi Tanabe Pharma Corporation | Composes azotes a noyau a cinq elements |
US6861440B2 (en) * | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
-
2002
- 2002-10-14 US US10/269,519 patent/US6861440B2/en not_active Expired - Fee Related
- 2002-10-18 IL IL16115802A patent/IL161158A0/xx unknown
- 2002-10-18 JP JP2003539671A patent/JP4171417B2/ja not_active Expired - Fee Related
- 2002-10-18 HU HU0402107A patent/HUP0402107A3/hu unknown
- 2002-10-18 DE DE60239629T patent/DE60239629D1/de not_active Expired - Lifetime
- 2002-10-18 AT AT02777318T patent/ATE503477T1/de active
- 2002-10-18 PL PL02370551A patent/PL370551A1/xx not_active Application Discontinuation
- 2002-10-18 AU AU2002338902A patent/AU2002338902B2/en not_active Ceased
- 2002-10-18 EA EA200400480A patent/EA007968B1/ru not_active IP Right Cessation
- 2002-10-18 CA CA2463709A patent/CA2463709C/fr not_active Expired - Fee Related
- 2002-10-18 NZ NZ531942A patent/NZ531942A/en unknown
- 2002-10-18 KR KR1020047006094A patent/KR100645671B1/ko not_active IP Right Cessation
- 2002-10-18 CN CN028209265A patent/CN1713907B/zh not_active Expired - Fee Related
- 2002-10-18 MX MXPA04003759A patent/MXPA04003759A/es active IP Right Grant
- 2002-10-18 BR BR0213539-6A patent/BR0213539A/pt not_active IP Right Cessation
- 2002-10-18 WO PCT/EP2002/011711 patent/WO2003037327A1/fr active Application Filing
- 2002-10-18 EP EP02777318A patent/EP1441719B1/fr not_active Expired - Lifetime
- 2002-10-23 PA PA20028557001A patent/PA8557001A1/es unknown
- 2002-10-24 AR ARP020104030A patent/AR036958A1/es not_active Application Discontinuation
- 2002-10-24 PE PE2002001048A patent/PE20030704A1/es not_active Application Discontinuation
- 2002-10-25 GT GT200200220AK patent/GT200200220AA/es unknown
- 2002-10-25 UY UY27518A patent/UY27518A1/es not_active Application Discontinuation
- 2002-10-25 GT GT200200220AA patent/GT200200220A/es unknown
-
2004
- 2004-03-29 IL IL161158A patent/IL161158A/en not_active IP Right Cessation
- 2004-04-15 HR HR20040344A patent/HRP20040344A2/hr not_active Application Discontinuation
- 2004-04-22 TN TNP2004000073A patent/TNSN04073A1/fr unknown
- 2004-04-23 MA MA27649A patent/MA26342A1/fr unknown
- 2004-04-23 NO NO20041709A patent/NO20041709L/no not_active Application Discontinuation
- 2004-10-18 YU YU34404A patent/YU34404A/sh unknown
- 2004-12-13 US US11/010,899 patent/US7314884B2/en not_active Expired - Fee Related
-
2007
- 2007-07-17 US US11/778,796 patent/US7803819B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4171417B2 (ja) | ジペプチジルペプチダーゼivインヒビターとしてのn−置換ピロリジン誘導体 | |
AU2002338902A1 (en) | N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors | |
EP2007732B1 (fr) | Thiazoles, imidazoles, et pyrazoles utiles en tant qu'inhibiteurs de protéines kinases | |
EP3305778B1 (fr) | Inhibiteurs de kallicreine plasmique | |
DE69830403T2 (de) | Inhibitoren des faktors xa mit einer neutralen gruppe mit p1-spezifität | |
US10221161B2 (en) | Inhibitors of plasma kallikrein | |
US7659283B2 (en) | Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases | |
EP3224255B1 (fr) | Composés n-((het)arylméthyl)-hétéroaryl-carboxamides en tant qu'inhibiteurs de kallikréine | |
KR20080065674A (ko) | 신규한 인돌 함유 베타 효능제, 이의 제조 방법 및약제로서의 이의 용도 | |
ES2360935T3 (es) | Derivados de pirrolidina n-sustituidos como inhibidores de la dipeptil peptidasa iv. | |
US7026324B2 (en) | Thrombin inhibitors | |
US20190152950A1 (en) | Inhibitors Of Plasma Kallikrein | |
RU2795572C2 (ru) | Соединения и композиции для ингибирования ire1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1OB | Publication of a patent application | ||
ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20071009 Year of fee payment: 6 |
|
OBST | Application withdrawn |